<SEC-DOCUMENT>0001493152-25-029791.txt : 20251231
<SEC-HEADER>0001493152-25-029791.hdr.sgml : 20251231
<ACCEPTANCE-DATETIME>20251231160533
ACCESSION NUMBER:		0001493152-25-029791
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20251229
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251231
DATE AS OF CHANGE:		20251231

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Glucotrack, Inc.
		CENTRAL INDEX KEY:			0001506983
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				980668934
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41141
		FILM NUMBER:		251617516

	BUSINESS ADDRESS:	
		STREET 1:		301 RT 17 NORTH
		STREET 2:		SUITE 800
		CITY:			RUTHERFORD
		STATE:			NJ
		ZIP:			07070
		BUSINESS PHONE:		972 (8) 675-7878

	MAIL ADDRESS:	
		STREET 1:		301 RT 17 NORTH
		STREET 2:		SUITE 800
		CITY:			RUTHERFORD
		STATE:			NJ
		ZIP:			07070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GlucoTrack, Inc.
		DATE OF NAME CHANGE:	20220328

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Integrity Applications, Inc.
		DATE OF NAME CHANGE:	20101203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:GCTK="http://glucotrack.com/20251229">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_GCTK_glucotrack.com_20251229 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20251229_20251229 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001506983 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000004" name="dei:EntityCentralIndexKey">0001506983</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gctk-20251229.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-12-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-29</xbrli:startDate>
        <xbrli:endDate>2025-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_901_edei--DocumentType_c20251229__20251229_zutR08a2QT7"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_904_edei--DocumentPeriodEndDate_c20251229__20251229_ziAqu5KGqf98"><ix:nonNumeric contextRef="AsOf2025-12-29" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">December 29, 2025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_901_edei--EntityRegistrantName_c20251229__20251229_zAGKTEldCgza"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000011" name="dei:EntityRegistrantName">GLUCOTRACK,
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20251229__20251229_zwRCbQFgLkGb"><ix:nonNumeric contextRef="AsOf2025-12-29" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityFileNumber_c20251229__20251229_z09RUpWKScRg"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000013" name="dei:EntityFileNumber">001-41141</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20251229__20251229_zEz7ZNb8H2e6"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000014" name="dei:EntityTaxIdentificationNumber">98-0668934</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or Other Jurisdiction</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    Incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20251229__20251229_zGGCZIgOPe9f"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000015" name="dei:EntityAddressAddressLine1">301
    Rte. 17 North</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20251229__20251229_zmXxiJevPUYf"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000016" name="dei:EntityAddressAddressLine2">Ste. 800</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressCityOrTown_c20251229__20251229_zqRgrberx3K1"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000017" name="dei:EntityAddressCityOrTown">Rutherford</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20251229__20251229_zuv7zCyrQJ8l"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000018" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityAddressPostalZipCode_c20251229__20251229_zLgmUE8wHG7g"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000019" name="dei:EntityAddressPostalZipCode">07070</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <span id="xdx_90D_edei--CityAreaCode_c20251229__20251229_zN8a3Iz0hlCd"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000020" name="dei:CityAreaCode">(201)</ix:nonNumeric></span> <span id="xdx_906_edei--LocalPhoneNumber_c20251229__20251229_z3UtMImtFr66"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000021" name="dei:LocalPhoneNumber">842-7715</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--WrittenCommunications_c20251229__20251229_zejuFb8HTAM6"><ix:nonNumeric contextRef="AsOf2025-12-29" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--SolicitingMaterial_c20251229__20251229_zCFNlNjYmD5f"><ix:nonNumeric contextRef="AsOf2025-12-29" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--PreCommencementTenderOffer_c20251229__20251229_zYEeLtS0wj9a"><ix:nonNumeric contextRef="AsOf2025-12-29" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20251229__20251229_zlA2BXNA5FDf"><ix:nonNumeric contextRef="AsOf2025-12-29" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--Security12bTitle_c20251229__20251229_zEAm52ZMJE02"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--TradingSymbol_c20251229__20251229_zSwKmgkkYwal"><ix:nonNumeric contextRef="AsOf2025-12-29" id="Fact000027" name="dei:TradingSymbol">GCTK</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--SecurityExchangeName_c20251229__20251229_zrPnu6qgX1U9"><ix:nonNumeric contextRef="AsOf2025-12-29" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;
230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167; 240.12b-2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_900_edei--EntityEmergingGrowthCompany_c20251229__20251229_zhD3JNHvUaj3"><ix:nonNumeric contextRef="AsOf2025-12-29" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2025, Glucotrack, Inc., a Delaware corporation (the &#8220;Company&#8221;), entered into a Securities Purchase Agreement
(the &#8220;Securities Purchase Agreement&#8221;) with an investor (the &#8220;Investor&#8221;) for a private placement of securities
(the &#8220;Private Placement&#8221;). The closing of the Private Placement occurred on December 31, 2025 (the &#8220;Closing&#8221;
and such date, the &#8220;Closing Date&#8221;). At the Closing, the Company issued 1,033,591 pre-funded warrants (the &#8220;Pre-Funded
Warrants&#8221;) to purchase 1,033,591 shares (the &#8220;Pre-Funded Warrant Shares&#8221;) of common stock, par value $0.001
per share (the &#8220;Common Stock&#8221;), at a purchase price of $3.87 per Pre-Funded Warrant less the exercise price per Pre-Funded
Warrant of $0.001 per share, and (ii) common warrants to purchase 2,067,182 shares (the &#8220;Common Warrant Shares&#8221; and together
with the Pre-Funded Warrant Shares, the &#8220;Warrant Shares&#8221;) of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received aggregate gross proceeds from the Private Placement of approximately $4.0 million, before deducting estimated placement
agent commissions and expenses in connection with the Private Placement, which are payable by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Securities Purchase Agreement contained customary representations, warranties and agreements by the Company, customary conditions to
closing, indemnification obligations of the Company and the Investor, other obligations of the parties and termination provisions. The
representations, warranties and covenants contained in the Securities Purchase Agreement were made only for purposes of such agreements
and as of specific dates, were solely for the benefit of the parties to such agreements, and may be subject to limitations agreed upon
by the contracting parties. The Company agreed to use the net proceeds from the Private Placement for general corporate purposes. The
Securities Purchase Agreement is governed by the laws of the State of New York.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also agreed that, from the date of the Securities Purchase Agreement until 60 days after the Effectiveness Date (as defined in
the Securities Purchase Agreement) (the &#8220;Effective Date&#8221;), the Company will not (i) issue, enter into any agreement to issue
or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents (as defined in the Securities
Purchase Agreement) or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated
pursuant to the Registration Rights Agreement. Further, until the 12-month anniversary of the Effective Date, the Company is prohibited
from effecting or entering into an agreement to effect any issuance by the Company or any of its subsidiaries of Common Stock or Common
Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction (as defined in the Securities Purchase Agreement),
subject to certain limited exceptions set forth in the Securities Purchase Agreement; provided, however, that, after 60 days following
the Effective Date, (i) the issuance and sale of shares of Common Stock in an &#8220;at the market&#8221; offering with the Placement
Agent (as defined herein) shall not be prohibited and (ii) sales of the Company&#8217;s Common Stock pursuant to the Company&#8217;s
equity line of credit, established pursuant to that certain Purchase Agreement dated September 11, 2025 by and between the Company and
Sixth Borough Capital Fund, LP shall not be prohibited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price of each Pre-Funded Warrant is equal to the closing price (as reflected on Nasdaq.com) of the Common Stock on December
29, 2025 (the &#8220;Minimum Price&#8221;), minus the exercise price of $0.001 per share. The Pre-Funded Warrants are exercisable at
any time after their original issuance, and will not expire until exercised in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Funded Warrants provide that the Investor will not have the right to exercise any portion of its Pre-Funded Warrants if such exercise
would cause (i) the aggregate number of shares of Common Stock beneficially owned by the Investor (together with its affiliates) to exceed
9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, or (ii) the combined voting
power of the Company&#8217;s securities beneficially owned by the Investor (together with its affiliates) to exceed 9.99% of the combined
voting power of all of the Company&#8217;s securities then outstanding immediately after giving effect to the exercise, as such percentage
ownership is determined in accordance with the terms of the Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Warrants have an exercise price per share of Common Stock equal to $3.87 per share (which is equal to the Minimum Price). The
Common Warrants are not exercisable, and the Common Warrant Shares are not issuable until the Company obtains stockholder approval
for such exercise and issuance under applicable rules and regulations of The Nasdaq Stock Market LLC (&#8220;Stockholder Approval&#8221;
and the date on which Stockholder Approval is received and deemed effective, the &#8220;Stockholder Approval Date&#8221;). The Common
Warrants will expire on the five year anniversary of the Stockholder Approval Date. The exercise price and the number of shares of Common
Stock issuable upon exercise of the Common Warrants is subject to appropriate adjustments in the event of certain stock dividends and
distributions, stock splits, stock combinations, reclassifications or similar events affecting the Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Warrants provide that the Investor will not have the right to exercise any portion of its Common Warrants if such exercise would
cause (i) the aggregate number of shares of Common Stock beneficially owned by the Investor (together with its affiliates) to
exceed 4.99% (or, at the election of the purchaser, 9.99%) of the number of shares of Common Stock outstanding immediately after giving
effect to the exercise, or (ii) the combined voting power of the Company&#8217;s securities beneficially owned by the Investor (together
with its affiliates) to exceed 4.99% (or, at the election of the purchaser, 9.99%) of the combined voting power of all of the Company&#8217;s
securities then outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance
with the terms of the Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Registration
Rights Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Private Placement, the Company entered into a Registration Rights Agreement with the Investor (the &#8220;Registration
Rights Agreement&#8221;). The Registration Rights Agreement provides that the Company shall file a registration statement covering the
resale of all of the Registrable Securities (as defined in the Registration Rights Agreement) with the U.S. Securities and Exchange Commission
(the &#8220;SEC&#8221;) no later than the 15th calendar day following the date of the Registration Rights Agreement, and have the registration
statement declared effective by the SEC as promptly as practicable after the filing thereof, but in any event no later than 45th calendar
day following the date of the Registration Rights Agreement, or in the event of a &#8220;full review&#8221; by the SEC, the 90th day
following the date of the Registration Rights Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the occurrence of any Event (as defined in the Registration Rights Agreement), which, among others, prohibits the Investor from reselling
the Securities for more than 10 consecutive calendar days or more than an aggregate of 15 calendar days during any 12-month period, the
Company is obligated to pay to the Investor, on each monthly anniversary of each such Event, an amount in cash, as partial liquidated
damages and not as a penalty, equal to the product of 1.5% multiplied by the aggregate subscription amount paid by such Investor pursuant
to the Securities Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may not file any other registration statements until all Registrable Securities are registered pursuant to a registration statement
that is declared effective by the SEC, provided that the Company may file amendments to registration statements filed prior to the date
of the Registration Rights Agreement so long as no new securities are registered on any such existing registration statements. All fees
and expenses incident to the performance of or compliance with the Registration Rights Agreement by the Company will be borne by the
Company, whether or not any Registrable Securities (as defined in the Registration Rights Agreement) are sold pursuant to a registration
statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lock-Up
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Private Placement, the Company&#8217;s officers and directors entered into lock-up agreements in favor of the
Placement Agent (each, a &#8220;Lock-Up Agreement&#8221;), pursuant to which, for a period of 90 days following the Closing, each
agreed, subject to certain limited exceptions, not to directly or indirectly, (a) offer for sale, sell, pledge, or otherwise
transfer or dispose of (or enter into any transaction that is designed to, or could reasonably be expected to, result in the
transfer or disposition by any person at any time in the future of) any shares of Common Stock or securities convertible into or
exercisable or exchangeable for Common Stock; (b) enter into any swap or other derivatives transaction that transfers to another, in
whole or in part, any of the economic benefits or risks of ownership of shares of Common Stock, whether any such transaction
described in clause (a) or (b) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise; (c)
make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with
respect to the registration of any shares of Common Stock or securities convertible into or exercisable or exchangeable for Common
Stock or any other securities of the Company; or (d) publicly disclose the intention to do any of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Placement
Agency Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Private Placement, on December 29, 2025, the Company entered into a Placement Agency Agreement (the &#8220;Placement
Agency Agreement&#8221;) with Curvature Securities, LLC (the &#8220;Placement Agent&#8221;). As part of its compensation for acting as
Placement Agent for the Private Placement, the Company paid the Placement Agent a cash fee of 7.0% of the aggregate gross proceeds and
issued to the Placement Agent warrants to purchase 124,030 shares of Common Stock (the &#8220;Placement Agent Warrant Shares&#8221;)
at an exercise price of $4.257 per share (the &#8220;Placement Agent Warrants&#8221;), which are exercisable at any time on or after
the date that is one hundred eighty (180) days from the date of the commencement of sales in connection with the Private Placement (the
&#8220;Commencement Date&#8221;), and expire on the five year anniversary of the Commencement Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above summary of the Pre-Funded Warrants, the Common Warrants, the Placement Agent Warrants, the Securities Purchase Agreement, the Registration
Rights Agreement, the Lock-Up Agreements and the Placement Agency Agreement does not purport to be complete and is qualified in its entirety
by reference to such applicable agreements or forms of agreements, copies of which are attached as Exhibits 4.1, 4.2, 4.3, 10.1, 10.2,
10.3 and 10.4, respectively, to this Current Report on Form 8-K and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02. Unregistered Sales of Equity Securities.</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained above in Item 1.01 of this Current Report on Form 8-K related to the Pre-Funded Warrants, Common Warrants, Placement
Agent Warrants, Warrant Shares and Placement Agent Warrant Shares is hereby incorporated
by reference into this Item 3.02. The Pre-Funded Warrants, Common Warrants, Placement Agent Warrants were sold without registration under
the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in reliance on the exemptions provided by Section 4(a)(2)
of the Securities Act as a transaction not involving a public offering and Rule 506(c) of Regulation D promulgated under the Securities
Act as sales to accredited investors and in reliance on similar exemptions under applicable state laws. When issued, the Warrant
Shares and Placement Agent Warrant Shares will be issued in reliance on the exemption from registration provided in Section 4(a)(2) under
the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 7.01 . Regulation FD Disclosure.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 30, 2025, the Company issued a press release announcing the pricing of the Private Placement. A copy of the press release is
attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this Item 7.01, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, unless the
Company specifically states that the information is to be considered &#8220;filed&#8221; under the Exchange Act or specifically incorporates
it by reference into a filing under the Securities Act or the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-1.htm">Form of Pre-Funded Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><a href="ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Common Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-3.htm">Form of Placement Agent Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><a href="ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Form of Registration Rights Agreement</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><a href="ex10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Lock-Up Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><a href="ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Agency Agreement, dated December 29, 2025, by and between the Company and Curvature Securities, LLC</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated December 30, 2025</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    December 31, 2025</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLUCOTRACK,
    INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Paul Goode</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Goode</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PdzWoeAuHTrEKTKGeFtclOLWjLT+PZJvad0QQyAk53wnQoSioJVukeG4qEqosetb5RAqPCOjOaF35OtNBn5WeNHWsTJuWH9gTp5Bz8wmqfL3wXnXFpsMEhmlcSSnEM8zOYf9VgRfPSdz1g0ap1ULyjSwZ+pZo1P8GhNq9SRD3Wv4dEC2moyPm8Sj/AYZJxJ2dFcP4quFssxFEA4ViILp1nvX8unQfElYttj5d3ak/x18AM91SmM= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLUCOTRACK,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant
    Shares:</B> 1,033,591</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issue
    Date: </B>December 31, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or
its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant
is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from <FONT STYLE="text-transform: uppercase"><B>Glucotrack,
Inc.,</B></FONT> a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to <B>1,033,591 shares</B> (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this
Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated December 29, 2025, among the Company and the purchaser
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise
                                            of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made,
                                            in whole or in part, at any time or times on or after the Initial Exercise Date and on or
                                            before the Termination Date by delivery to the Company of a duly executed facsimile copy
                                            or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form
                                            annexed hereto as <U>Exhibit A</U> (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
                                            the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the
                                            Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise
                                            as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares
                                            specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check
                                            drawn on a United States bank unless the cashless exercise procedure specified in Section
                                            2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise
                                            shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
                                            of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the
                                            Holder shall not be required to physically surrender this Warrant to the Company until the
                                            Holder has purchased all of the Warrant Shares available hereunder and this Warrant has been
                                            exercised in full, in which case, the Holder shall surrender this Warrant to the Company
                                            for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
                                            is delivered to the Company. Partial exercises of this Warrant resulting in purchases of
                                            a portion of the total number of Warrant Shares available hereunder shall have the effect
                                            of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
                                            to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain
                                            records showing the number of Warrant Shares purchased and the date of such purchases. The
                                            Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day
                                            of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant,
                                            acknowledge and agree that, by reason of the provisions of this paragraph, following the
                                            purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
                                            for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise
                                            Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price
                                            of $0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise
                                            Date and, consequently, no additional consideration (other than the nominal exercise price
                                            of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to
                                            effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund
                                            of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
                                            or for any reason whatsoever. The remaining unpaid exercise price per share of Common Stock
                                            under this Warrant shall be $0.001, subject to adjustment hereunder (the &ldquo;<U>Exercise
                                            Price</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cashless
                                            Exercise</U>. If at the time of exercise hereof there is no effective registration statement
                                            registering, or the prospectus contained therein is not available for the issuance or resale
                                            of the Warrant Shares to or by the Holder, then this Warrant may also be exercised, in whole
                                            or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder
                                            shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by
                                            dividing [(A-B) (X)] by (A), where:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 93.15pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the
    Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
    Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution
    of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
    Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
    on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date
    of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof
    after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery
of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by
the date that is the earlier of (A) the earlier of (i) one (1) Trading Day and (ii) the number of days comprising the Standard Settlement
Period, in each case after the delivery to the Company of the Notice of Exercise and (B) one (1) Trading Day after delivery of the aggregate
Exercise Price to the Company (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise,
the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise
Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails for any reason
to cause its transfer agent to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which
may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares
subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant
Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received by such Warrant Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.8in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.8in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.8in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 81pt; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 81pt; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 81pt; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 81pt; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto as <U>Exhibit B</U> duly executed by the Holder
and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the
Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic
delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;Attribution Parties&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written request of a Holder,
the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which
such number of outstanding shares of Common Stock was reported. The &ldquo;Beneficial Ownership Limitation&rdquo; shall be 9.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder, upon written notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant
held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the
extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any direct or indirect purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of (x) 50% or more of the outstanding Common
Stock or (y) 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or
more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires more than (x) 50% of the voting power of the common equity of
the Company or (y) 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or
other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase
agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of
this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section
3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares
of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and
the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to,
and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other
Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right
and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents
with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notice
                                            to Holder</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Adjustment
                                            to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision
                                            of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email
                                            a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
                                            to the number of Warrant Shares and setting forth a brief statement of the facts requiring
                                            such adjustment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notice
                                            to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other
                                            distribution in whatever form) on the Common Stock, (B) the Company shall declare a special
                                            nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
                                            authorize the granting to all holders of the Common Stock rights or warrants to subscribe
                                            for or purchase any shares of capital stock of any class or of any rights, (D) the approval
                                            of any stockholders of the Company shall be required in connection with any reclassification
                                            of the Common Stock, any consolidation or merger to which the Company is a party, any sale
                                            or transfer of all or substantially all of the assets of the Company, or any compulsory share
                                            exchange whereby the Common Stock is converted into other securities, cash or property, or
                                            (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or
                                            winding up of the affairs of the Company, then, in each case, the Company shall cause to
                                            be delivered by facsimile or email to the Holder at its last facsimile number or email address
                                            as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior
                                            to the applicable record or effective date hereinafter specified, a notice stating (x) the
                                            date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
                                            rights or warrants, or if a record is not to be taken, the date as of which the holders of
                                            the Common Stock of record to be entitled to such dividend, distributions, redemption, rights
                                            or warrants are to be determined or (y) the date on which such reclassification, consolidation,
                                            merger, sale, transfer or share exchange is expected to become effective or close, and the
                                            date as of which it is expected that holders of the Common Stock of record shall be entitled
                                            to exchange their shares of the Common Stock for securities, cash or other property deliverable
                                            upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided
                                            that the failure to deliver such notice or any defect therein or in the delivery thereof
                                            shall not affect the validity of the corporate action required to be specified in such notice.
                                            To the extent that any notice provided in this Warrant constitutes, or contains, material,
                                            non-public information regarding the Company or any of the Company&rsquo;s subsidiaries,
                                            the Company shall simultaneously file such notice with the Commission pursuant to a Current
                                            Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the
                                            period commencing on the date of such notice to the effective date of the event triggering
                                            such notice except as may otherwise be expressly set forth herein.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant
and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to
receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash
settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>. The Company covenants that, at all times during the period the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise
of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under
this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the
Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action, which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLUCOTRACK,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paul V. Goode</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Exhibit
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
<B>GLUCOTRACK, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 81pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 81pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 81pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ______________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 9.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 9.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4-2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLUCOTRACK,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant
    Shares:</B> 2,067,182 </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Issuance
    Date:</B> December 31, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or
its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the Stockholder Approval Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on
or prior to 5:00 p.m. (New York City time) on the five year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from <FONT STYLE="text-transform: uppercase"><B>Glucotrack, Inc.,</B></FONT> a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), up to <B>2,067,182 shares</B> (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal
to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated December 29, 2025, among the Company and the purchaser
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as <B><U>Exhibit A</U></B>
(the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and
this Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within
three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant
resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be $3.87, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance or resale of the Warrant Shares to or by the Holder, then this Warrant may also be
exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive
a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 93.15pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the
    Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
    Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution
    of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
    Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
    on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date
    of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof
    after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery of Warrant Shares
  Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder
  by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its
  Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either
  (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by
  the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered
  in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
  is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier
  of (A) the earlier of (i) one (1) Trading Day and (ii) the number of days comprising the Standard Settlement Period, in each case after
  the delivery to the Company of the Notice of Exercise and (B) one (1) Trading Day after delivery of the aggregate Exercise Price to
  the Company (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder
  shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant
  has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price
  (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails for any reason
  to cause its transfer agent to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
  Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
  to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
  to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant
  Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer
  agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
  Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
  Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.8in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.8in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.8in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0pt; width: 1.25in; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
  of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
  and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
  evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
  in all other respects be identical with this Warrant.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Rescission
  Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
  by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Compensation
  for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder,
  if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of
  Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
  by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
  of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
  such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
  the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
  (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
  with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
  at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
  was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
  that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
  Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
  of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
  preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
  the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
  herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
  limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver
  shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></TD></TR>

</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0pt; text-indent: 0pt; width: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
  Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
  Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
  at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
  Exercise Price or round up to the next whole share.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Charges,
  Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
  incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
  and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
  <U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
  surrendered for exercise shall be accompanied by the Assignment Form attached hereto as <U>Exhibit B</U> duly executed by the Holder
  and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
  thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the
  Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic
  delivery of the Warrant Shares.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Closing
  of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this
  Warrant, pursuant to the terms hereof.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;Attribution Parties&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written request of a Holder,
the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which
such number of outstanding shares of Common Stock was reported. The &ldquo;Beneficial Ownership Limitation&rdquo; shall be 4.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder, upon written notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant
held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">f)
Notwithstanding anything to the contrary contained in this Warrant, this Warrant may not be exercised pursuant to this Section 2 until
the Initial Exercise Date.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the
extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer
or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to
sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of (x) 50% or more
of the outstanding Common Stock or (y) 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly
or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of shares of Common
Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged for other
securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or
share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than (x) 50%
or more of the outstanding Common Stock or (y) 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined
below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within thirty (30) days after, the consummation
of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase
this Warrant from the Holder by paying to the Holder, as described below, an amount of consideration equal to the Black Scholes Value
(as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction,
provided, however, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s
Board of Directors, Holder shall only be entitled to receive from the Company or any Successor Entity, as of the date of the consummation
of such Fundamental Transaction the same type or form of consideration (and in the same proportion), valued at the Black Scholes Value
of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection
with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the
holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental
Transaction; provided further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental
Transaction, such holders of Common Stock will be deemed to have received shares of the Successor Entity (which Successor Entity may
be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;Black Scholes Value&rdquo; means the value
of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as
of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate
corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to 100 day volatility obtained from the
HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following the public
announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater
of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the announcement
of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the
Trading Day of the Holder&rsquo;s request pursuant to this Section 3(d) and (D) a remaining option time equal to the time between the
date of the public announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The
payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five Business Days of the Holder&rsquo;s
election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant
to written agreements in form and substance reasonably satisfactory to the Holder prior to such Fundamental Transaction and shall, at
the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written
instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise
of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an
exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value
of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of
shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior
to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon
the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after
the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named
as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Company&rsquo;s subsidiaries, the Company shall simultaneously file
such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during
the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be
expressly set forth herein.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant
and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to
receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash
settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>. The Company covenants that, at all times during the period the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise
of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under
this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the
Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action, which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLUCOTRACK,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paul V. Goode</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Exhibit
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
<B>GLUCOTRACK, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 81pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 81pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 81pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ______________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 9.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 9.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ex4-3.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
4.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Placement
Agent </B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMON STOCK PURCHASE WARRANT</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLUCOTRACK,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant
  Shares: 124,030</B></FONT></TD>
  <TD STYLE="text-align: right; padding-left: 0pt; text-indent: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuance
  Date</B>: December 31, 2025</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Curvature Securities LLC or its
assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date that is one hundred eighty (180) days from the Commencement Date (as defined below) (the
&ldquo;<U>Initial Exercise Date</U>&rdquo;) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to 5:00 p.m. (New York time) on December
31, 2030, the date that is five (5) years following the Commencement Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter,
to subscribe for and purchase from <B>GLUCOTRACK, INC.</B>, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to <B>124,030
shares</B> (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The purchase
price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 16.2pt; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Placement Agency Agreement (the &ldquo;<U>Placement Agency Agreement</U>&rdquo;), dated December 29, 2025, among the Company and Curvature
Securities LLC (the &ldquo;<U>Placement Agent</U>&rdquo;). In addition, &ldquo;<U>Commencement Date</U>&rdquo; means the date of the
commencement of sales of the securities issued pursuant to the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 16.2pt; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as <B><U>Exhibit A</U></B>
(the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and
this Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within
three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant
resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 33.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 33.3pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 33.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$4.26</B>, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance or resale of the Warrant Shares to or by the Holder, then this Warrant may also be
exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive
a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the
    Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
    Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution
    of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
    Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
    on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date
    of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof
    after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
                                            of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased
                                            hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account
                                            of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
                                            through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the
                                            Company is then a participant in such system and either (A) there is an effective registration
                                            statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares
                                            by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise
                                            by physical delivery of a certificate, registered in the Company&rsquo;s share register in
                                            the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
                                            is entitled pursuant to such exercise to the address specified by the Holder in the Notice
                                            of Exercise by the date that is the earlier of (A) the earlier of (i) one (1) Trading Day
                                            and (ii) the number of days comprising the Standard Settlement Period, in each case after
                                            the delivery to the Company of the Notice of Exercise and (B) one (1) Trading Day after delivery
                                            of the aggregate Exercise Price to the Company (such date, the &ldquo;<U>Warrant Share Delivery
                                            Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for
                                            all corporate purposes to have become the holder of record of the Warrant Shares with respect
                                            to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
                                            Shares, provided that payment of the aggregate Exercise Price (other than in the case of
                                            a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails
                                            for any reason cause the transfer agent to to deliver to the Holder the Warrant Shares subject
                                            to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the
                                            Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares
                                            subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
                                            Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth
                                            Trading Day after such liquidated damages begin to accrue) for each Trading Day after such
                                            Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such
                                            exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
                                            program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
                                            Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number
                                            of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common
                                            Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
                                            of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the
                                            Company shall, at the request of a Holder and upon surrender of this Warrant certificate,
                                            at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
                                            the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant,
                                            which new Warrant shall in all other respects be identical with this Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Rescission
                                            Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the
                                            Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder
                                            will have the right to rescind such exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Compensation
                                            for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to
                                            any other rights available to the Holder, if the Company fails to cause the Transfer Agent
                                            to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
                                            2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if
                                            after such date the Holder is required by its broker to purchase (in an open market transaction
                                            or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
                                            Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the
                                            Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the
                                            Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
                                            total purchase price (including brokerage commissions, if any) for the shares of Common Stock
                                            so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares
                                            that the Company was required to deliver to the Holder in connection with the exercise at
                                            issue times (2) the price at which the sell order giving rise to such purchase obligation
                                            was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant
                                            and equivalent number of Warrant Shares for which such exercise was not honored (in which
                                            case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares
                                            of Common Stock that would have been issued had the Company timely complied with its exercise
                                            and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
                                            a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
                                            of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation
                                            of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required
                                            to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
                                            the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company,
                                            evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to
                                            pursue any other remedies available to it hereunder, at law or in equity including, without
                                            limitation, a decree of specific performance and/or injunctive relief with respect to the
                                            Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
                                            as required pursuant to the terms hereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
                                            Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares
                                            shall be issued upon the exercise of this Warrant. As to any fraction of a share which the
                                            Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at
                                            its election, either pay a cash adjustment in respect of such final fraction in an amount
                                            equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Charges,
                                            Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder
                                            for any issue or transfer tax or other incidental expense in respect of the issuance of such
                                            Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
                                            Shares shall be issued in the name of the Holder or in such name or names as may be directed
                                            by the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are
                                            to be issued in a name other than the name of the Holder, this Warrant when surrendered for
                                            exercise shall be accompanied by the Assignment Form attached hereto as <B><U>Exhibit B</U></B>
                                            duly executed by the Holder and the Company may require, as a condition thereto, the payment
                                            of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
                                            shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise
                                            and all fees to the Depository Trust Company (or another established clearing corporation
                                            performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Closing
                                            of Books</U>. The Company will not close its stockholder books or records in any manner which
                                            prevents the timely exercise of this Warrant, pursuant to the terms hereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written request of a Holder,
the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which
such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99%
of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of this Warrant. The Holder, upon written notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant
held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
Notwithstanding anything to the contrary contained in this Warrant, this Warrant may not be exercised pursuant to this Section 2 until
the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 16.2pt; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the
extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise, other than cash (including, without limitation, any distribution of stock or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer
or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to
sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of (x) 50% or more
of the outstanding Common Stock or (y) 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly
or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of shares of Common
Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged for other
securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or
share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than (x) 50%
or more of the outstanding Common Stock or (y) 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined
below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within thirty (30) days after, the consummation
of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase
this Warrant from the Holder by paying to the Holder, as described below, an amount of consideration equal to the Black Scholes Value
(as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction,
provided, however, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s
Board of Directors, Holder shall only be entitled to receive from the Company or any Successor Entity, as of the date of the consummation
of such Fundamental Transaction the same type or form of consideration (and in the same proportion), valued at the Black Scholes Value
of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection
with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the
holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental
Transaction; provided further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental
Transaction, such holders of Common Stock will be deemed to have received shares of the Successor Entity (which Successor Entity may
be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means
the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined
as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to 100 day volatility obtained from the
HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following the public
announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater
of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the announcement
of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the
Trading Day of the Holder&rsquo;s request pursuant to this Section 3(d) and (D) a remaining option time equal to the time between the
date of the public announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The
payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five Business Days of the Holder&rsquo;s
election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant
to written agreements in form and substance reasonably satisfactory to the Holder prior to such Fundamental Transaction and shall, at
the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written
instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise
of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an
exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value
of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of
shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior
to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon
the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after
the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;<U>Company</U>&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named
as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 48.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.8in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Company&rsquo;s subsidiaries, the Company shall simultaneously file
such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during
the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be
expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 16.2pt; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 16.2pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 16.2pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Pursuant to FINRA Rule 5110(e)(1)(A), neither this Warrant nor any Warrant Shares issued upon exercise of this
Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put,
or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days
immediately following the Commencement Date, except the transfer of any security:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            operation of law or by reason of reorganization of the Company;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
                                            to any FINRA member firm participating in the offering and the officers or partners thereof,
                                            if all securities so transferred remain subject to the lock-up restriction in this Section
                                            4(a) for the remainder of the time period;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the aggregate amount of securities of the Company held by the Holder or related person do
                                            not exceed 1% of the securities being offered;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided
                                            that no participating member manages or otherwise directs investments by the fund, and participating
                                            members in the aggregate do not own more than 10% of the equity in the fund; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            exercise or conversion of any security, if all securities received remain subject to the
                                            lock-up restriction in this Section 4(a) for the remainder of the time period.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, as described in this Section 4(a), upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant
and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to
receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash
settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>. The Company covenants that, at all times during the period the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise
of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under
this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the
Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action, which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Placement Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Placement
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Placement Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLUCOTRACK,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paul
    V. Goode</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Exhibit
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
<B>GLUCOTRACK, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 81pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 81pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 9.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 9.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 9.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 9.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 43%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 1.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: center; text-indent: -.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: center; text-indent: -.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of December 29, 2025, between Glucotrack, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the purchasers identified on the signature pages hereto (including its successors
and assigns, the &ldquo;<U>Purchaser</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below)
and/or Rule 506 of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser,
severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the words and terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following
words and terms have the meanings set forth in this <U>Section 1.1</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.5</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Laws</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(jj)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Authorizations</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(jj)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 2.1(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(ii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>BSA/PATRIOT
Act</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.2(j)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close; <U>provided</U>,
<U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay
at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the
closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems
(including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to <U>Section 2.1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchaser&rsquo;s obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first (1st) Trading
Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or its subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with <U>Section 2.2(a)</U> hereof, which Common Warrants shall be exercisable on and after the date that is six (6) months following
the Stockholder Approval Date and have a term of exercise equal to five (5) years following the Stockholder Approval Date, substantially
in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Nelson Mullins Riley &amp; Scarborough LLP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Control</U>&rdquo;
(including the terms &ldquo;<U>Controlled by</U>&rdquo; and &ldquo;<U>under common Control with</U>&rdquo;) means the possession, directly
or indirectly, of the power to direct or cause the direction of the management and policies of a person, whether through the ownership
of voting securities, as trustee or executor, by contract or otherwise, including the ownership, directly or indirectly, of securities
having the power to elect a majority of the board of directors or similar body governing the affairs of such person or securities that
represent a majority of the outstanding voting securities of such person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disqualification
Event</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(kk)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Registration Statement required to be filed pursuant to the Registration Rights Agreement,
the closing of business, Eastern Time, on the 45<SUP>th</SUP> calendar day following the date hereof (or, in the event of a &ldquo;limited
review&rdquo; by the Commission, the 60<SUP>th</SUP> calendar day following the date hereof or, in the event of a &ldquo;full review&rdquo;
by the Commission, the 90<SUP>th</SUP> calendar day following the date hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means (i) the issuance of securities to directors, officers, employees and consultants of the Company pursuant to
employee benefit plans, equity incentive plans or other employee compensation plans existing on the date hereof and as described in the
SEC Reports or pursuant to Nasdaq Rule 5635(c)(4), (ii) the issuance of securities upon the exercise or exchange of or conversion of
any Securities issued hereunder and/or the issuance of securities pursuant to the exercise, exchange or conversion of any options, warrants,
restricted stock units, rights or convertible securities outstanding on the date hereof, provided that such options, warrants, restricted
stock units, rights or convertible securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of such securities, (iii)
securities issued pursuant to merger, acquisition, or strategic transactions approved by a majority of the disinterested directors of
the Company, <I>provided</I> that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry
no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition
period in <U>Section 4.12(a)</U> herein, and <I>provided</I>, <I>further </I>that any such issuance shall only be to a Person (or to
the equity holders of a Person) that is, itself or through its subsidiaries, an operating company, or an owner of an asset in a business
synergistic with the business of the Company and in which the Company receives benefits in addition to any investment of funds, but shall
not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose
primary business is investing in securities, and (iv) securities for settlement of outstanding payables or liabilities <I>provided</I>
that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that
require or permit the filing of any registration statement in connection therewith during the prohibition period in <U>Section 4.12(a)</U>
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended, as used in <U>Section 3.1(aa)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(nn)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDCA</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(nn)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Food
and Drug Regulations</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(nn)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FTC</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(oo)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(f)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GDPR</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(pp)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(qq)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
Covered Persons</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(kk)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
Free Writing Prospectus</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(f)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>IT
Systems and Data</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(ee)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(n)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreements</U>&rdquo; means the lock-up agreements in substantially the form of <U>Exhibit B</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in <U>Section 3.1(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $3.87, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date, provided
that the purchase price per Pre-Funded Warrant shall be the Per Share Purchase Price minus $0.001.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Curvature Securities LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Policies</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(pp)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in
accordance with <U>Section 2.2(a)</U> hereof, in the form of <U>Exhibit C</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Privacy
Laws</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(pp)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, a preliminary inquiry, an informal investigation
or a partial proceeding, such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Product</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(nn)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser</U>&rdquo;
shall have the meaning ascribed to such term in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.8</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers,
in the form of <U>Exhibit D</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(f)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of The Nasdaq Stock Market LLC (or
any successor entity) from the stockholders of the Company to consent to any exercise of the Warrants and issuance of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval Date</U>&rdquo; means the date on which Stockholder Approval is received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares, Pre-Funded Warrants (if applicable) and Common
Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading
&ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds (excluding for the avoidance of doubt,
if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid as and when such
Pre-Funded Warrants are exercised for cash).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
of any person means any corporation, partnership, limited liability company, joint stock company, joint venture or other organization
or entity, whether incorporated or unincorporated, which is Controlled by such Person, and shall, where applicable, also include any
direct or indirect subsidiary of the Company formed or acquired after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Pre-Funded Warrants, the Common Warrants, the Lock-Up Agreements, the Placement Agency
Agreement, the Registration Rights Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed
in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Vstock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Pl, Woodmere,
NY 11598, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.12(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of each of the Common Warrants and the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASE
AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the
Purchasers, severally and not jointly, agree to purchase approximately $4,000,000 of the Securities, which includes, (i) the number of
Shares set forth under the heading &ldquo;Subscription Amount&rdquo; on the Purchaser&rsquo;s signature page hereto, at the Per Share
Purchase Price, and (ii) Common Warrants exercisable for shares of Common Stock as calculated pursuant to <U>Section 2.2(a)</U>. Notwithstanding
anything herein to the contrary, to the extent that any Purchaser determines, in its sole discretion, that the Purchaser&rsquo;s Subscription
Amount would cause such Purchaser&rsquo;s beneficial ownership of the shares of Common Stock to exceed the Beneficial Ownership Limitation,
or as such Purchaser may otherwise choose, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of the Shares as determined
pursuant to <U>Section 2.2(a)</U>. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, at the election of each
Purchaser at Closing, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of the Securities on the Closing Date. Each Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed
by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) settlement with the Company
or its designees. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Pre-Funded Warrants) delivered
on or prior to 12:00 p.m. (New York City time) on the Closing Date, which may be delivered at any time after the time of execution of
this Agreement, the Company agrees to deliver the Pre-Funded Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time)
on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the Pre-Funded Warrants) for purposes
hereunder, provided that payment of the aggregate Exercise Price (as defined in the Pre-Funded Warrants) (other than in the case of a
cashless exercise) is received by such Warrant Share Delivery Date. The Company and each Purchaser shall deliver the other items set
forth in <U>Section 2.2</U> deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in <U>Sections 2.2</U>
and <U>2.3</U>, the Closing shall occur remotely or such location as the parties shall mutually agree. Settlement of the Shares shall
occur via DVP when such Purchaser makes payment of the Subscription Amount by wire transfer of immediately available funds to a bank
account designated by the Company, upon which payment the Company shall issue the Shares registered in such Purchaser&rsquo;s name and
address and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by such Purchaser; upon receipt
of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
                                            Agreement duly executed by the Company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            legal opinion of Company Counsel in a form reasonably acceptable to the Placement Agent;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on
                                            Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent
                                            to deliver on an expedited basis a certificate (or book entry statement) evidencing a number
                                            of Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase
                                            Price, registered in the name of such Purchaser, or, at the election of such Purchaser, evidence
                                            of the issuance of such Purchaser&rsquo;s Shares hereunder as held in DRS book-entry form
                                            by the Transfer Agent and registered in the name of such Purchaser, which evidence shall
                                            be reasonably satisfactory to such Purchaser;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            applicable, for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded
                                            Warrant registered in the name of such Purchaser to purchase up to a number of shares of
                                            Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable
                                            to Pre-Funded Warrants divided by the Per Share Purchase Price minus $0.001, with an exercise
                                            price equal to $0.001 per share of Common Stock, subject to adjustment therein;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            Common Warrant registered in the name of each Purchaser to purchase up to a number of shares
                                            of Common Stock equal to 200% of the Purchaser&rsquo;s Shares, with an exercise price equal
                                            to $3.87, subject to adjustment therein;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Registration Rights Agreement duly executed by the Company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            Officer&rsquo;s Certificate, in form and substance reasonably satisfactory to the Placement
                                            Agent;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            Secretary&rsquo;s Certificate, in form and substance reasonably satisfactory to the Placement
                                            Agent; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Lock-Up Agreements duly executed by each executive officer and director of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the
                                            Company the following:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
                                            Agreement duly executed by such Purchaser;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Purchaser&rsquo;s Subscription Amount, which shall be made available for DVP settlement with
                                            the Company or its designees; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Registration Rights Agreement duly executed by such Purchaser.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            accuracy in all material respects (or, to the extent representations or warranties are qualified
                                            by materiality or Material Adverse Effect, in all respects) when made and on the Closing
                                            Date of the representations and warranties of the Purchasers contained herein (unless as
                                            of a specific date therein in which case they shall be accurate as of such date);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            obligations, covenants and agreements of each Purchaser required to be performed at or prior
                                            to the Closing Date shall have been performed; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            delivery by each Purchaser of the items set forth in <U>Section 2.2(b)</U> of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 2.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of each Purchaser in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            accuracy in all material respects (or, to the extent representations or warranties are qualified
                                            by materiality or Material Adverse Effect, in all respects) when made and on the Closing
                                            Date of the representations and warranties of the Company contained herein (unless as of
                                            a specific date therein in which case they shall be accurate as of such date);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            obligations, covenants and agreements of the Company required to be performed at or prior
                                            to the Closing Date shall have been performed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            delivery by the Company of the items set forth in <U>Section 2.2(a)</U> of this Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            shall have been no Material Adverse Effect with respect to the Company since the date hereof;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">from
                                            the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended
                                            by the Commission or the Company&rsquo;s principal Trading Market, and, at any time prior
                                            to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
                                            not have been suspended or limited, or minimum prices shall not have been established on
                                            securities whose trades are reported by such service, or on any Trading Market, nor shall
                                            a banking moratorium have been declared either by the United States or New York State authorities
                                            nor shall there have occurred any material outbreak or escalation of hostilities or other
                                            national or international calamity of such magnitude in its effect on, or any material adverse
                                            change in, any financial market which, in each case, in the reasonable judgment of the Purchaser,
                                            makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall
be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the
corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to the Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization and Good Standing</U>. Each of the subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. Each of the Company
and its subsidiaries has been duly incorporated or organized, as applicable, is validly existing and is in good standing (to the extent
the concept of good standing is applicable in such jurisdiction) under the laws of its jurisdiction of incorporation or organization.
Each of the Company and its subsidiaries has the requisite power and authority to own its properties and conduct its business as currently
being carried on and as described in the SEC Reports, and is duly qualified to do business as a foreign corporation or other entity in
good standing in each jurisdiction in which the conduct of its business or ownership of property makes such qualification necessary and
in which the failure to so qualify would have (A) a material adverse effect upon the business, properties, operations, financial condition
or results of operations of the Company and its subsidiaries, taken as a whole, or (B) a material adverse effect on the Company&rsquo;s
ability to perform in any material respect on a timely basis its obligations under the Transaction Documents (&ldquo;<U>Material Adverse
Effect</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Violations or Defaults</U>. Neither the Company nor any of its subsidiaries (A) is in violation of its respective charters, bylaws
or other organizational documents, (B) is in breach of or otherwise in default and no event has occurred which, with notice or lapse
of time or both, would constitute such a default, in the performance or observance of any term, covenant or condition contained in any
contract, indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a party or by which
it is bound or to which any of its material property or assets is subject, or (C) is in violation in any respect of any law, ordinance,
governmental rule, regulation or court order, decree or judgment to which it or its property or assets may be subject, including the
Sarbanes&ndash;Oxley Act and the Exchange Act; except, in the case of clauses (A), (B) and (C) of this paragraph (b), for any breaches,
violations or defaults which, singularly or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; No Conflicts; Authority</U>. This Agreement has been duly authorized, executed and delivered by the Company, and constitutes
a valid, legal and binding obligation of the Company, enforceable in accordance with its terms, except as rights to indemnity hereunder
may be limited by federal or state securities laws and except as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting the rights of creditors generally and subject to general principles of equity. The Registration Rights Agreement
has been duly authorized, executed and delivered by the Company, and constitutes a valid, legal and binding obligation of the Company,
enforceable in accordance with its terms, except as rights to indemnity hereunder may be limited by federal or state securities laws
and except as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors
generally and subject to general principles of equity. Subject to the Stockholder Approval, the Warrants have been duly authorized, and
when executed and delivered by the Company, shall constitute a valid, legal and binding obligation of the Company, enforceable in accordance
with their terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the
rights of creditors generally and subject to general principles of equity. Subject to the Stockholder Approval, the execution, delivery
and performance of the Transaction Documents and the consummation of the transactions herein and therein contemplated will not (A) conflict
with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation
or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to any
indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is
a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of
its subsidiaries is subject and which is material to the Company and its subsidiaries taken as a whole, (B) result in any violation of
the provisions of the Company&rsquo;s charter or by-laws or (C) result in the violation of any law or statute or any judgment, order,
rule, regulation or decree of any court or arbitrator or federal, state, local or foreign governmental agency or regulatory authority
having jurisdiction over the Company or any of its subsidiaries or any of their properties or assets (each, a &ldquo;<U>Governmental
Authority</U>&rdquo;), except in the case of clause (A) or (C) as would not result in a Material Adverse Effect. No consent, approval,
authorization or order of, or registration or filing with any Governmental Authority is required for the execution, delivery and performance
of this Agreement or for the consummation of the transactions contemplated hereby, including the issuance or sale of the Shares by the
Company, except such as may be required under the Act, the rules of the Financial Industry Regulatory Authority (&ldquo;<U>FINRA</U>&rdquo;)
or state securities or blue sky laws; and the Company has full power and authority to enter into the Transaction Documents and to consummate
the transactions contemplated hereby and thereby, including the authorization, issuance and sale of the Securities as contemplated by
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Issuance of the Securities; Registration</U>. The Shares are duly authorized and, when issued and paid for in accordance with the
applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed
by the Company. When paid for and issued in accordance with this Agreement, the Warrants will constitute valid and binding obligations
of the Company, enforceable against the Company in accordance with their respective terms, except as such enforceability may be limited
by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general principles
of equity. The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable,
free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number
of Shares issuable pursuant to this Agreement shall reserve from its duly authorized capital stock the maximum number of Warrant Shares
issuable pursuant to the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(e</U>). All of the
issued and outstanding shares of capital stock of the Company, including the outstanding shares of Common Stock, are duly authorized
and validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state and foreign securities laws,
were not issued in violation of or subject to any preemptive rights or other rights to subscribe for or purchase securities that have
not been waived in writing, and the holders thereof are not subject to personal liability by reason of being such holders; the capital
stock of the Company, including the Common Stock, conforms in all material respects to the description thereof in the SEC Reports. Except
as set forth on <U>Schedule 3.1(e</U>), (A) there are no preemptive rights or other rights to subscribe for or to purchase, or any restriction
upon the voting or transfer of, any shares of Common Stock pursuant to the Company&rsquo;s charter, by-laws or any agreement or other
instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound; and
(B) neither the filing of the Registration Statement nor the offering or sale of the Securities as contemplated by this Agreement gives
rise to any rights for or relating to the registration of any shares of Common Stock or other securities of the Company (collectively
&ldquo;<U>Registration Rights</U>&rdquo;), except as have been validly waived or complied with in connection with the sale of Securities
as contemplated by this Agreement. No further approval or authorization of any stockholder, the Board of Directors or others is required
for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with
respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any
of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>SEC Reports</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two (2) years preceding
the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials,
including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &ldquo;<U>SEC
Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior
to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i)
under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing. Such financial
statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis
during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes
thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material
respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations
and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
The selected financial data set forth under the caption &ldquo;Selected Financial Data&rdquo; in the SEC Reports fairly present, on the
basis stated in such SEC Reports, the information included therein. The agreements and documents described in the SEC Reports conform
in all material aspects to the descriptions thereof contained therein and there are no agreements or other documents required by the
Securities Act and the rules and regulations thereunder to be described in the SEC Reports, that have not been so described or filed.
Each agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound
or affected and (A) that is referred to in SEC Reports, or (B) is material to the Company&rsquo;s business, has been duly authorized
and validly executed by the Company, is in full force and effect in all material respects and is enforceable against the Company and,
to the Company&rsquo;s knowledge, the other parties thereto, in accordance with its terms, except (i) as such enforceability may be limited
by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally, (ii) as enforceability of any
indemnification or contribution provision may be limited under the federal and state securities laws, and (iii) that the remedy of specific
performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the
court before which any proceeding therefore may be brought. None of such agreements or instruments has been assigned by the Company,
and neither the Company nor, to the best of the Company&rsquo;s knowledge, any other party is in default thereunder and, to the best
of the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute
a default thereunder. To the Company&rsquo;s knowledge, performance by the Company of the material provisions of such agreements or instruments
will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency
or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation,
those relating to environmental laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Financial Statements</U>. The financial statements of the Company, together with the related notes, set forth or incorporated by reference
in the SEC Reports comply in all material respects with the requirements of the Securities Act and the Exchange Act and fairly present
the financial condition of the Company and its consolidated subsidiaries as of the dates indicated and the results of operations and
changes in cash flows for the periods therein specified in conformity with generally accepted accounting principles in the United States
consistently applied throughout the periods involved; the supporting schedules included in the Registration Statement present fairly
the information required to be stated therein; all non-GAAP financial information included in the SEC Reports complies with the requirements
of Regulation G and Item 10 of Regulation S-K under the Act; and, except as disclosed in the SEC Reports, there are no material off-balance
sheet arrangements (as defined in Regulation S-K under the Act, Item 303(a)(4)(ii)) or any other relationships with unconsolidated entities
or other persons, that may have a material current effect or, to the Company&rsquo;s knowledge, material future effect on the Company&rsquo;s
financial condition, results of operations, liquidity, capital expenditures, capital resources or significant components of revenue or
expenses. No other financial statements or schedules are required to be included in the SEC Reports. To the Company&rsquo;s knowledge,
each of the Company&rsquo;s current independent accounting firm, CBIZ CPAs P.C. (&ldquo;<U>CBIZ</U>&rdquo;), and former independent accounting
firm, Fahn Kanne &amp; Co. Grant Thornton Israel (&ldquo;<U>Grant Thornton</U>&rdquo;), with Grant Thornton having expressed its opinion
with respect to the financial statements and schedules filed as a part of the SEC Reports and included in the SEC Reports is and was,
as the case may be (A) an independent public accounting firm within the meaning of the Act and the Rules and Regulations, (B) a registered
public accounting firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act of 2002 (the &ldquo;<U>Sarbanes-Oxley Act</U>&rdquo;))
and (C) CBIZ is not in violation of the auditor independence requirements of the Sarbanes-Oxley Act, and Grant Thornton was not in violation
of the auditor independence requirements of the Sarbanes-Oxley Act when they served as the Company&rsquo;s independent public accounting
firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Absence of Certain Events; Undisclosed Events, Liabilities or Developments</U>. Subsequent to the respective dates as of which information
is given in the SEC Reports, neither the Company nor any of its subsidiaries has (A) incurred any material liabilities, direct or contingent,
other than trade payables and accrued expenses incurred in the ordinary course of business consistent with past practices and liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to generally accepted accounting principles or disclosed
in filings made with the SEC; (B) declared or paid any dividends or made any distribution of any kind with respect to its capital stock;
(C) there has not been any change in the capital stock of the Company (other than a change in the number of outstanding shares of Common
Stock due to the issuance of shares upon the exercise of outstanding options or warrants, settlement of restricted stock units or conversion
of convertible securities); (D) any issuance of options, warrants, restricted stock units, convertible securities or other rights to
purchase the capital stock of the Company or any of its subsidiaries, or (E) any event or development that has had a Material Adverse
Effect or any development which could reasonably be expected to result in any Material Adverse Effect. Except for (i) the issuance of
the Securities contemplated by this Agreement, or (ii) as set forth on <U>Schedule 3.1(h)</U>, no material event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries
or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Absence of Proceedings</U>. There is not pending or, to the knowledge of the Company, threatened, any action, suit or proceeding (A)
to which the Company or any of its subsidiaries is a party or (B) which has as the subject thereof any officer or director of the Company
or any subsidiary, any employee benefit plan sponsored by the Company or any subsidiary or any property or assets owned or leased by
the Company or any subsidiary before or by any court or Governmental Authority, or any arbitrator, which, individually or in the aggregate,
would reasonably be expected to result in any Material Adverse Effect, or would materially and adversely affect the ability of the Company
to perform its obligations under the Transaction Documents. There are no current or, to the knowledge of the Company, pending, legal,
governmental or regulatory actions, suits or proceedings (i) to which the Company or any of its subsidiaries is subject or (ii) which
has as the subject thereof any officer or director of the Company or any subsidiary, any employee plan sponsored by the Company or any
subsidiary or any property or assets owned or leased by the Company or any subsidiary, that are required to be described in the SEC Reports
by the Securities Act or by the Rules and Regulations and that have not been so described in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Labor Relations</U>. No material labor dispute with the employees of the Company or any of its subsidiaries exists or, to the Company&rsquo;s
knowledge, is threatened or imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of
any of its or its subsidiaries&rsquo; principal suppliers, contractors or customers, that would reasonably be expected to have a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>[Reserved]</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance with Environmental Laws</U>. Except as disclosed in the SEC Reports, neither the Company nor any of its subsidiaries is
(A) in violation of any statute, any rule, regulation, decision or order of any Governmental Authority or any court, domestic or foreign,
relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment
or human exposure to hazardous or toxic substances (collectively, &ldquo;<U>Environmental Laws</U>&rdquo;), (B) owns or operates any
real property contaminated with any substance that is subject to any environmental laws, (C) is liable for any off-site disposal or contamination
pursuant to any Environmental Laws, or (D) is subject to any claim relating to any Environmental Laws, which violation, contamination,
liability or claim would individually or in the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Ownership of Assets</U>. The Company and its subsidiaries have good and marketable title to all property (whether real or personal)
described in the SEC Reports as being owned by them which is material to the Company and its subsidiaries taken as a whole, in each case
free and clear of all liens, claims, security interests, other encumbrances or defects except such as are described in the SEC Reports
or as would not, individually or in the aggregate, be reasonably expected to result in a Material Adverse Effect. The property held under
lease by the Company and its subsidiaries is held by them under valid, subsisting and enforceable leases with only such exceptions with
respect to any particular lease as do not interfere in any material respect with the conduct of the business of the Company or its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Intellectual Property</U> The Company and each of its subsidiaries owns, possesses, or can acquire on reasonable terms, all Intellectual
Property (as defined below) necessary for the conduct of the Company&rsquo;s and it subsidiaries&rsquo; business as now conducted or
as described in the SEC Reports to be conducted, except as such failure to own, possess, or acquire such rights would not reasonably
be expected to result in a Material Adverse Effect. Furthermore, except as described in the SEC Reports, (A) to the knowledge of the
Company after reasonable investigation (&ldquo;<U>Knowledge</U>&rdquo;), there is no infringement, misappropriation or violation by third
parties of any such Intellectual Property, except as such infringement, misappropriation or violation would not result in a Material
Adverse Effect; (B) there is no pending or, to the Knowledge of the Company, threatened, action, suit, proceeding or claim by others
challenging the Company&rsquo;s or any of its subsidiaries&rsquo; rights in or to any such Intellectual Property, and the Company is
unaware of any objective facts which would form a reasonable basis for any such claim; (C) the Intellectual Property owned by the Company
and its subsidiaries, and to the Knowledge of the Company, the Intellectual Property licensed to the Company and its subsidiaries, has
not been adjudged invalid or unenforceable, in whole or in part, and there is no pending or, to the Knowledge of the Company, threatened
action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property; (D) there is no pending
or, to the Knowledge of the Company, threatened action, suit, proceeding or claim by others that the Company or any of its subsidiaries
infringes, misappropriates or otherwise violates any Intellectual Property or other proprietary rights of others, and neither the Company
or any of its subsidiaries has received any written notice of such claim; and (E) to the Company&rsquo;s knowledge, no employee of the
Company or any of its subsidiaries is in or has ever been in violation of any term of any employment contract, patent disclosure agreement,
invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant
to or with a former employer where the basis of such violation relates to such employee&rsquo;s employment with the Company or any of
its subsidiaries or actions undertaken by the employee while employed with the Company or any of its subsidiaries, except as such violation
would not result in a Material Adverse Effect. &ldquo;<U>Intellectual Property</U>&rdquo; shall mean all patents, patent applications,
trademarks, trademark registrations, service marks, service mark registrations, trade names, copyrights, copyright registrations, licenses,
inventions, trade secrets, Internet domain names, Internet domain name registrations, technology, registrations, trade secret rights,
know-how and other intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Insurance</U>. The Company and each of its subsidiaries carries, or is covered by, insurance from insurers of recognized financial
responsibility in such amounts and covering such risks as is customary for companies engaged in similar businesses in similar industries;
all policies of insurance and any fidelity or surety bonds insuring the Company or any of its subsidiaries or its business, assets, employees,
officers and directors are in full force and effect, except as would not have a Material Adverse Effect; the Company and its subsidiaries
are in compliance with the terms of such policies and instruments in all material respects; and neither the Company nor any of its subsidiaries
has reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Internal Accounting Controls</U>. The Company and its subsidiaries maintain a system of internal accounting controls sufficient to
provide reasonable assurances that (A) transactions are executed in accordance with management&rsquo;s general or specific authorization;
(B) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting
principles in the United States and to maintain accountability for assets; (C) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets
at reasonable intervals and appropriate action is taken with respect to any differences. Since the end of the latest audited fiscal year,
there has been no change in the Company&rsquo;s internal control over financial reporting (whether or not remediated) that has materially
affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control over financial reporting. The Company&rsquo;s
board of directors has, subject to the exceptions, cure periods and the phase in periods specified in the applicable stock exchange rules
(<I>&ldquo;</I><U>Exchange Rules</U>&rdquo;), validly appointed an audit committee to oversee internal accounting controls whose composition
satisfies the applicable requirements of the Exchange Rules and the Company&rsquo;s board of directors and/or the audit committee has
adopted a charter that satisfies the requirements of the Exchange Rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Certain Fees</U>. Except for fees payable to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be
payable by the Company or any subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by the Transaction Documents. Each Purchaser shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this
Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Investment Company</U>. The Company is not and, after giving effect to the offering and sale of the Securities, will not be an &ldquo;investment
company,&rdquo; as such term is defined in the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth on <U>Schedule 3.1(s)</U>, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance
with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in
the foreseeable future continue to be, in compliance with all such listing and maintenance requirements, except as set forth on <U>Schedule
3.1(s)</U>. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established
clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing
corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination or other similar anti-takeover provision under the Company&rsquo;s
certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable
to each Purchaser as a result of each Purchaser and the Company fulfilling their obligations or exercising their rights under the Transaction
Documents, including without limitation as a result of the Company&rsquo;s issuance of the Securities and the Purchaser&rsquo;s ownership
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided to each Purchaser or its agents or counsel
with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed
in the SEC Reports. The Company understands and confirms that each Purchaser will rely on the foregoing representation in effecting transactions
in securities of the Company. All of the disclosure furnished by or on behalf of the Company to each Purchaser regarding the Company
and its subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this
Agreement, when taken together as a whole, is true and correct and does not contain any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were
made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with
respect to the transactions contemplated hereby other than those specifically set forth in <U>Section 3.2</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchaser&rsquo;s representations and warranties set forth in <U>Section
3.2</U>, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of
the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of
any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Private Placement</U>. Assuming the accuracy of the Purchaser&rsquo;s representations and warranties set forth in <U>Section 3.2</U>,
no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>[Reserved]</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Tax Status</U>. The Company and its subsidiaries (A) have timely filed all federal, state, local and foreign income and franchise
tax returns required to be filed and (B) are not in default in the payment of any taxes which were payable pursuant to said returns or
any assessments with respect thereto, other than any which the Company or any of its subsidiaries is contesting in good faith; except
those, in each of the cases described in clauses (A) and (B) of this paragraph (z), that would not, singularly or in the aggregate, reasonably
be expected to have a Material Adverse Effect. There is no pending material dispute with any taxing authority relating to any of such
returns, and the Company has no knowledge of any proposed material liability for any tax to be imposed upon the properties or assets
of the Company for which there is not an adequate reserve reflected in the Company&rsquo;s financial statements included in the SEC Reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Anti-Bribery and Anti-Money Laundering Laws</U>. Each of the Company, its subsidiaries, its affiliates and any of their respective
officers, directors, supervisors, managers, agents, or employees, each in their respective roles with the Company, has not violated,
its participation in the offering will not violate, and the Company and each of its subsidiaries has instituted and maintains policies
and procedures designed to ensure continued compliance in all material respects with, each of the following laws: anti-bribery laws,
including but not limited to, any applicable law, rule, or regulation of any locality in which the Company does business, including but
not limited to any applicable law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public
Officials in International Business Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977
(the &ldquo;<U>FCPA</U>&rdquo;), as amended, the U.K. Bribery Act 2010 (to the extent applicable), or any other applicable law, rule
or regulation of similar purposes and scope, or anti-money laundering laws, including but not limited to, applicable federal, state,
international, foreign or other laws, regulations or government guidance regarding anti-money laundering, including, without limitation,
Title 18 US. Code section 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international anti-money laundering principles or
procedures by an intergovernmental group or organization, such as the Financial Action Task Force on Money Laundering, of which the United
States is a member and with which designation the United States representative to the group or organization continues to concur, all
as amended, and any executive order, directive, or regulation pursuant to the authority of any of the foregoing, or any orders or licenses
issued thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Acknowledgment Regarding Purchaser&rsquo;s Purchase of Securities</U>. The Company acknowledges and agrees that each Purchaser is
acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that each Purchaser is not acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by each
Purchaser or any of its respective representatives or agents in connection with the Transaction Documents and the transactions contemplated
thereby is merely incidental to the Purchaser&rsquo;s purchase of the Securities. The Company further represents to each Purchaser that
the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent
evaluation of the transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for <U>Sections 3.2(f)</U> and <U>4.14</U> hereof), it is understood and acknowledged by the Company that: (A) each Purchaser
has not been asked by the Company to agree, nor has each Purchaser agreed, to desist from purchasing or selling, long and/or short, securities
of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (B) past or future open market or other transactions by the Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (C) the Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions, if any, to which each Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in
the Common Stock, and (D) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (i) each Purchaser may engage in hedging
activities at various times during the period that the Securities are outstanding, and (ii) such hedging activities (if any) could reduce
the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being
conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction
Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (A) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (B) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (C) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (B) and (C), compensation paid to the Placement Agent in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Cybersecurity</U>. Except as would not, individually or in the aggregate, have a Material Adverse Effect, (A) the Company and the
Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any
court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and
security of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software,
data (including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf
of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and to the protection of such IT Systems and
Data from unauthorized use, access, misappropriation or modification; (B) the Company and the Subsidiaries have implemented and maintained
commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation,
redundancy and security of all IT Systems and Data; and (C) the Company and the Subsidiaries have implemented backup and disaster recovery
technology consistent with commercially reasonable industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Stock Option Plans</U>. Except as described in the SEC Reports, there are no options, warrants, restricted stock units, agreements,
contracts or other rights in existence to purchase or acquire from the Company or any subsidiary of the Company any shares of the capital
stock of the Company or any subsidiary of the Company. The description of the Company&rsquo;s stock option, stock bonus and other stock
plans or arrangements (the &ldquo;<U>Company Stock Plans</U>&rdquo;), and the options (the &ldquo;<U>Options</U>&rdquo;) or other rights
granted thereunder, set forth in the SEC Reports accurately and fairly presents the information required to be shown with respect to
such plans, arrangements, options and rights. Each grant of an Option (A) was duly authorized no later than the date on which the grant
of such Option was by its terms to be effective by all necessary corporate action, including, as applicable, approval by the board of
directors of the Company (or a duly constituted and authorized committee thereof) and any required shareholder approval by the necessary
number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party
thereto and (B) was made in accordance in all material respects with the terms of the applicable Company Stock Plan, and all applicable
laws and regulatory rules or requirements, including all applicable federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon a Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its
subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Regulatory</U>. Except as described on <U>Schedule 3.1(f)</U>, the Company and its Subsidiaries (A) are and at all times have been
in material compliance with all statutes, rules and regulations applicable to the Company including, without limitation, the federal
Anti-Kickback Statute (42 U.S.C. &sect; 1320a-7b(b)), the regulations promulgated pursuant to such laws, and any successor government
programs and comparable state laws, and all other local, state, federal, national, supranational and foreign laws, manual provisions,
policies and administrative guidance relating to the regulation of the Company (collectively, the &ldquo;<U>Applicable Laws</U>&rdquo;);
(B) have not received any notice from any court or arbitrator or governmental or regulatory authority or third party alleging or asserting
noncompliance with any Applicable Laws or any licenses, exemptions, certificates, approvals, clearances, authorizations, permits, registrations
and supplements or amendments thereto required by any such Applicable Laws (&ldquo;<U>Authorizations</U>&rdquo;); (C) possess all material
Authorizations and such Authorizations are valid and in full force and effect and are not in violation of any term of any such Authorizations;
(D) have not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation arbitration or other
action from any court or arbitrator or governmental or regulatory authority or third party alleging that any product operation or activity
is in violation of any Applicable Laws or Authorizations nor is any such claim, action, suit, proceeding, hearing, enforcement, investigation,
arbitration or other action threatened; (E) have not received any written notice that any court or arbitrator or governmental or regulatory
authority has taken, is taking or intends to take, action to limit, suspend, materially modify or revoke any Authorizations nor is any
such limitation, suspension, modification or revocation threatened; (F) have filed, obtained, maintained or submitted all material reports,
documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws
or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or
amendments were complete and accurate on the date filed (or were corrected or supplemented by a subsequent submission); and (G) are not
a party to any corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with
or imposed by any governmental or regulatory authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>No Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act)
connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer
Covered Persons</U>&rdquo;) is subject to any of the &ldquo;<U>Bad Actor</U>&rdquo; disqualifications described in Rule 506(d)(1)(i)
to (viii) under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule
506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Other Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person)
that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Notice of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing
Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time,
become a Disqualification Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Food and Drug Regulations</U>. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (the &ldquo;<U>FDA</U>&rdquo;)
under the Federal Food, Drug and Cosmetic Act, and the regulations thereunder (the &ldquo;<U>FDCA</U>&rdquo;) and similar or comparable
governmental authorities located in other countries and laws, rules and regulations relating to registration, investigational use, premarket
clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product
listing, quotas, labeling, advertising, record keeping and filing of reports, including, without limitation in foreign jurisdictions
(collectively, &ldquo;<U>Food and Drug Regulations</U>&rdquo;), that is manufactured, packaged, labeled, tested, distributed, sold, and/or
marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Product</U>&rdquo;), such Product is being manufactured,
packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable requirements under applicable
Food and Drug Regulations, except where the failure to be in compliance would not have or would reasonably be expected to have a Material
Adverse Effect or as is disclosed in the SEC Reports. Except as disclosed in the SEC Reports, there is no pending, completed or, to the
Company&rsquo;s knowledge, threatened, Proceeding against the Company or any of its Subsidiaries, and none of the Company or any of its
Subsidiaries has received any notice, warning letter or other communication arising from or relating to Food and Drug Regulations, which
(A) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or
packaging of, the testing of, the sale of, or the labeling and promotion of any Product, (B) withdraws its approval of, requests the
recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any
Product, (C) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (D) enjoins production
at any facility of the Company or any of its Subsidiaries, (E) enters or proposes to enter into a consent decree of permanent injunction
with the Company or any of its Subsidiaries, or (F) otherwise alleges any violation of any laws, rules or regulations by the Company
or any of its Subsidiaries (including Food and Drug Regulations), and which, either individually or in the aggregate, would have or would
reasonably be expected to have a Material Adverse Effect. The properties, business and operations of the Company have been and are being
conducted in all material respects in accordance with all applicable Food and Drug Regulations. The Company has not been informed by
the FDA or any other governmental authority that such governmental authority will prohibit the marketing, sale, license or use in the
United States or in another jurisdiction of any product proposed to be developed, produced or marketed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (A) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (B) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (C) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to the FDA and comparable foreign regulators,
the U.S. Federal Trade Commission (&ldquo;<U>FTC</U>&rdquo;), state unfair trade practice laws and rules and foreign equivalents, taxes,
environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each
case as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Compliance with Data Privacy Laws</U>. (A) The Company and the Subsidiaries are, and at all times during the last three (3) years
were, in material compliance with all applicable state, federal and foreign data privacy and security laws and regulations, including,
without limitation, the European Union General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;) (EU 2016/679) (collectively, &ldquo;<U>Privacy
Laws</U>&rdquo;); (B) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to
ensure compliance with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure,
handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); (C) the Company provides accurate notice
of its applicable Policies to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and
(D) applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating to its
subject matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy
Laws. &ldquo;<U>Personal Data</U>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph,
social security number, bank information, or customer or account number; (ii) any information which would qualify as &ldquo;personally
identifying information&rdquo; under the FTC, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR; and (iv) any other piece
of information that allows the identification of such natural person, or his or her family, or permits the collection or analysis of
any identifiable data related to an identified person&rsquo;s health or sexual orientation. (y) None of such disclosures made or contained
in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (z) the execution, delivery
and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company nor the
Subsidiaries (1) to the knowledge of the Company, has received written notice of any actual or potential liability of the Company or
the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws; (2) is currently
conducting or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to any regulatory request
or demand pursuant to any Privacy Law; or (3) is a party to any order, decree, or agreement by or with any court or arbitrator or governmental
or regulatory authority that imposed any obligation or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (A) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (B) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business
as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (C) the
current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). Except as disclosed in the SEC Reports,
the Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation
under the bankruptcy or reorganization laws of any jurisdiction within one (1) year from the Closing Date. The SEC Reports set forth
as of the date of this Agreement and as of the Closing Date, respectively, all outstanding secured and unsecured Indebtedness of the
Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo;
means (i) any liabilities for borrowed money or amounts owed in excess of Fifty Thousand Dollars ($50,000) (other than trade accounts
payable incurred in the ordinary course of business), (ii) all guaranties, endorsements and other contingent obligations in respect of
indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the
notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary
course of business; and (iii) the present value of any lease payments in excess of One Hundred Thousand Dollars ($100,000) due under
leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchaser</U>. Each Purchaser hereby represents and warrants as of the date hereof and as of
the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 78.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Each Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by each Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of the Purchaser. Each Transaction Document to which
it is a party has been duly executed by the Purchaser, and when delivered by each Purchaser in accordance with the terms hereof, will
constitute the valid and legally binding obligation of the Purchaser, enforceable against it in accordance with its terms, except: (i)
as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Understandings or Arrangements</U>. Each Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting the Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or
otherwise in compliance with applicable federal and state securities laws). Each Purchaser is acquiring the Securities hereunder in the
ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time each Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7)under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a) under the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 78.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 78.3pt"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 78.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of the Purchaser</U>. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Each Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>No General Solicitation</U>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of
any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media
or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation
or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Access to Information</U>. Each Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (A) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (B) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (C) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Each Purchaser acknowledges and agrees that neither
the Placement Agent nor any Affiliate of the Placement Agent has provided each Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which each Purchaser agrees need not be provided to it. In connection with the issuance of the
Securities to the Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to the
Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 78.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, each Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with the Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that each Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Other than to other Persons party
to this Agreement or to the Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal
and other advisors, employees, agents and Affiliates, each Purchaser has maintained the confidentiality of all disclosures made to it
in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance
of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or
borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Brokers</U>. No agent, broker, investment banker, person or firm acting in a similar capacity on behalf of or under the authority
of the Purchaser is or will be entitled to any broker&rsquo;s or finder&rsquo;s fee or any other commission or similar fee, directly
or indirectly, for which the Company or any of its Affiliates after the Closing could have any liabilities in connection with this Agreement,
any of the transactions contemplated by this Agreement, or on account of any action taken by the Purchaser in connection with the transactions
contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Independent Advice</U>. Each Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf
of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Sanctioned Persons; BSA/PATRIOT Act</U>. Purchaser is not owned or controlled by or acting on behalf of (in connection with this Agreement),
a Sanctioned Person. Purchaser is not an institution that accepts currency for deposit and that (A) has no physical presence in the jurisdiction
in which it is incorporated or in which it is operating and (B) is unaffiliated with a regulated financial group that is subject to consolidated
supervision (a &ldquo;<U>Shell Bank</U>&rdquo;) or providing banking services to a Shell Bank. Purchaser represents that if it is a financial
institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.), as amended by the USA PATRIOT Act of 2001 and its implementing
regulations (collectively, the &ldquo;<U>BSA/PATRIOT Act</U>&rdquo;), that Purchaser maintains policies and procedures reasonably designed
to comply with applicable obligations under the BSA/PATRIOT Act. Purchaser also represents that, to the extent required by applicable
law, it maintains, either directly or through the use of a third-party administrator, policies, and procedures reasonably designed for
the screening of any investors in the Purchaser against Sanctions-related lists of blocked or restricted persons. Purchaser further represents
and warrants that (i) the funds held by Purchaser and used to purchase the Securities were not directly or indirectly derived from or
related to any activities that may contravene U.S. federal, state, or non-U.S. anti-money laundering, anti-corruption, or Sanctions laws
and regulations or activities that may otherwise be deemed criminal and (ii) any returns from the Purchaser&rsquo;s investment will not
be used to finance any illegal activities. For purposes of this Agreement, &ldquo;<U>Sanctioned Person</U>&rdquo; means at any time any
person or entity with whom dealings are restricted, prohibited, or sanctionable under any Sanctions (as defined below), including as
a result of being: (x) listed on any Sanctions-related list of designated or blocked or restricted persons; (y) that is a national of,
the government of, or any agency or instrumentality of the government of, or resident in, or organized under the laws of, a country or
territory that is the target of comprehensive Sanctions from time to time (as of the date of this Agreement, Cuba, Iran, North Korea,
Syria, and the Crimea region); or (z) a relationship of ownership, control, or agency with any of the foregoing. &ldquo;<U>Sanctions</U>&rdquo;
means those trade, economic and financial sanctions laws, regulations, embargoes, and restrictive measures (in each case having the force
of law) administered, enacted, or enforced from time to time by (1) the United States (including without limitation the U.S. Department
of the Treasury, Office of Foreign Assets Control, the U.S. Department of State, and the U.S. Department of Commerce), (2) the European
Union and enforced by its member states, (3) the United Nations, and (4) the United Kingdom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 18.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 18.9pt"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 18.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this <U>Section 3.2</U> shall not modify, amend or affect the Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Transfer Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in <U>Section 4.1(b)</U>, the Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and
the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration
Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Purchasers agree to the imprinting, so long as is required by this <U>Section 4.1</U>, of a legend on any of the Securities in the
following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY
NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER
LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR
OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of
any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act
to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Certificates evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in <U>Section 4.1(b)</U>
hereof), (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective
under the Securities Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 (assuming cashless exercise of
the Warrants), (iii) if requested by a Purchaser, if such Shares or Warrant Shares are eligible for sale under Rule 144 (assuming cashless
exercise of the Warrants) or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial
interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion
to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent to effect the removal of the
legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Warrant is exercised at a time when there
is an effective registration statement to cover the resale of the Warrant Shares, or if such Shares or Warrant Shares may be sold under
Rule 144 and the Company is then in compliance with the current public information required under Rule 144 (assuming cashless exercise
of the Warrants), or if the Shares or Warrant Shares may be sold under Rule 144 without the requirement for the Company to be in compliance
with the current public information required under Rule 144 as to such Shares or Warrant Shares or if such legend is not otherwise required
under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the
Commission) then such Warrant Shares shall be issued free of all legends. The Company agrees that following the Effective Date, it will,
no later than the earlier of (i) one (1) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as
defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares or Warrant
Shares, as the case may be, issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), cause the Company&rsquo;s
Transfer Agent to deliver to such Purchaser a certificate representing such shares that is free from all restrictive and other legends.
The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer
set forth in this <U>Section 4</U>. Certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer
Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed
by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in
a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of
delivery of a certificate representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (A) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after the Legend Removal Date) for each Trading Day after the Legend Removal
Date until such certificate is delivered without a legend and (B) if the Company fails to (i) issue and deliver (or cause to be delivered)
to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that
is free from all restrictive and other legends and (ii) if after the Legend Removal Date such Purchaser purchases (in an open market
transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the
number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares
of Common Stock, that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal to the
excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for
the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In
Price</U>&rdquo;) over the product of (y) such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser
by the Legend Removal Date multiplied by (z) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing
on the date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending
on the date of such delivery and payment under this <U>Section 4.1(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or
an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information; Public Information</U>. Until the earliest of the time that (a) no Purchaser owns Securities and (b) the
Common Warrants have expired, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of
the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports
required to be filed by the Company after the date hereof pursuant to the Exchange Act, even if the Company is not then subject to the
reporting requirements of the Exchange Act, except in the event that the Company consummates (A) any transaction or series of related
transactions as a result of which any Person (together with its Affiliates) acquires then outstanding securities of the Company representing
more than fifty percent (50%) of the voting control of the Company; (B) a merger or reorganization of the Company with one or more other
entities in which the Company is not the surviving entity; or (C) a sale of all or substantially all of the assets of the Company, where
the consummation of such transaction results in the Company no longer subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction
unless stockholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. The Company covenants and agrees that neither it, nor any
other Person acting on its behalf will provide each Purchaser or its respective agents or counsel with any information that constitutes,
or the Company reasonably believes constitutes, material non-public information, unless prior thereto each Purchaser shall have consented
to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. In addition, effective
upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its subsidiaries or any of their respective officers, directors,
agents, employees or Affiliates on the one hand, and each Purchaser or any of its Affiliates on the other hand, shall terminate. The
Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated
hereby, and neither the Company nor each Purchaser shall issue any such press release nor otherwise make any such public statement without
the prior consent of the Company, with respect to any press release of the Purchaser, or without the prior consent of the Purchaser,
with respect to any press release of the Company which names the Purchaser, which consent shall not unreasonably be withheld or delayed,
except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice
of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of the Purchaser,
or include the name of each Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior
written consent of the Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction
Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the
Company shall provide each Purchaser with prior notice of such disclosure permitted under this clause (b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>[Reserved].</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Furnishing of Information.</U> The Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act, even if the Company
is not then subject to the reporting requirements of the Exchange Act, except in the event that the Company consummates: (a) any transaction
or series of related transactions as a result of which any Person (together with its Affiliates) acquires then outstanding securities
of the Company representing more than fifty percent (50%) of the voting control of the Company; (b) a merger or reorganization of the
Company with one or more other entities in which the Company is not the surviving entity; or (c) a sale of all or substantially all of
the assets of the Company, where the consummation of such transaction results in the Company no longer being subject to the reporting
requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time during the period commencing from the later of the Stockholder Approval Date and the six (6) month anniversary of the date hereof
and ending at such time that all of the Securities may be sold without the requirement for the Company to be in compliance with Rule
144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy
the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes
an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information
Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash,
as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities,
an amount in cash equal to one and one-half percent (1.5%) of the Subscription Amount of such Purchaser&rsquo;s Securities on the day
of a Public Information Failure and on every thirtieth (30<SUP>th</SUP>) day (pro rated for periods totaling less than thirty days) thereafter
until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer
required for the Purchasers to transfer the Shares and Warrant Shares pursuant to Rule 144, provided, however, that in no event will
the aggregate amount of liquidated damages paid by the Company to a Purchaser exceed twelve percent (12%) of such Purchaser&rsquo;s Subscription
Amount. The payments to which a Purchaser shall be entitled pursuant to this Section 4.6 are referred to herein as &ldquo;<U>Public Information
Failure Payments</U>.&rdquo; Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month
during which such Public Information Failure Payments are incurred and (ii) the third (3<SUP>rd</SUP>) Business Day after the event or
failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information Failure
Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for
partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public Information
Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate purposes,
which shall include the preparation and filing of all outstanding reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, including
the documents set forth in <U>Section 4.20(i)</U> of this Agreement, and funding its working capital needs, but shall not use such proceeds:
(a) for the redemption of any Common Stock or Common Stock Equivalents, or (b) in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of the Purchaser</U>. Subject to the provisions of this <U>Section 4.8</U>, the Company will indemnify and hold each
Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally
equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls each
Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or
incur as a result of or relating to (a) any material breach of any of the representations, warranties, covenants or agreements made by
the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against each Purchaser Parties in any
capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser
Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material
breach of such Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or
understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal
securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or
willful misconduct), or (c) in connection with the Registration Statement the Company will indemnify each Purchaser Party, to the fullest
extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation,
reasonable attorneys&rsquo; fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged untrue statement
of a material fact contained in such registration statement, any prospectus or any form of prospectus or in any amendment or supplement
thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required
to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in the light of
the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that such untrue statements
or omissions are based solely upon information regarding such Purchaser Party furnished in writing to the Company by such Purchaser Party
expressly for use therein, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state
securities law, or any rule or regulation thereunder in connection therewith. If any action shall be brought against any Purchaser Party
in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing,
and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to each Purchaser
Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof,
but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x) the employment
thereof has been specifically authorized by the Company in writing, (y) the Company has failed after a reasonable period of time to assume
such defense and to employ counsel or (z) in such action there is, in the reasonable opinion of counsel, a material conflict on any material
issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for
the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under
this Agreement (1) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not
be unreasonably withheld or delayed; or (2) to the extent, but only to the extent that a loss, claim, damage or liability is attributable
to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party
in this Agreement or in the other Transaction Documents. The indemnification required by this <U>Section 4.8</U> shall be made by periodic
payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred; provided,
however, that if it is subsequently determined by a final, non-appealable judgment of a court of competent jurisdiction that each Purchaser
was not entitled to receive such payments, each Purchaser shall promptly (but in no event later than five (5) Business Days) return such
payments to the Company. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any
Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and the Warrant Shares pursuant to any exercise of the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Listing of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation
of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply
to list or quote all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and
Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other
Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is
necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible.
The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market
and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading
Market. The Company agrees to use commercially reasonable efforts to maintain the eligibility of the Common Stock for electronic transfer
through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of
fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>[Reserved].</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Subsequent Equity Sales</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until sixty (60) days after the Effectiveness Date, , neither the Company nor any Subsidiary shall (i) issue, enter
into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents,
or (ii) file any registration statement or amendment or supplement thereto, other than a Registration Statement pursuant to the Registration
Rights Agreement or filing a registration statement on Form S-8 in connection with any employee benefit plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until twelve (12) months after the Effectiveness Date, the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a
combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or
include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other
price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the
initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset
at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events
directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction
under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at the market offering&rdquo;, whereby the
Company may issue securities at a future determined price regardless of whether shares pursuant to such agreement have actually been
issued and regardless of whether such agreement is subsequently canceled; <U>provided</U>, <U>however</U>, that (A) commencing sixty
(60) days after the Effectiveness Date, the Company&rsquo;s issuance of Common Stock or Common Stock Equivalents pursuant to an &ldquo;at
the market offering&rdquo; facility with the Placement Agent as sales agent shall not be deemed a Variable Rate Transaction; and (B)
sales of the Company&rsquo;s securities beginning sixty (60) days after the Effectiveness Date pursuant to the ELOC (as defined below)
shall not be deemed a Variable Rate Transaction. The Company entered into a Purchase Agreement dated September 11, 2025 with Sixth Borough
Capital Fund, LP to sell securities pursuant to an equity line of credit (the &ldquo;<U>ELOC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this <U>Section 4.12</U> shall not apply in respect of an Exempt Issuance, except that no Variable Rate
Transaction shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Equal Treatment of Purchasers.</U> No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Certain Transactions and Confidentiality</U>. Each Purchaser covenants that neither it nor any Affiliate acting on its behalf or pursuant
to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company&rsquo;s securities during
the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in <U>Section 4.4</U>. Each Purchaser covenants that
until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press
release as described in <U>Section 4.4</U>, each Purchaser will maintain the confidentiality of the existence and terms of this transaction,
and the information included in the Disclosure Schedules. Notwithstanding the foregoing, and notwithstanding anything contained in this
Agreement to the contrary, the Company expressly acknowledges and agrees that (i) each Purchaser makes no representation, warranty or
covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) each
Purchaser shall not be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable
securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in <U>Section 4.4</U>, and (iii) each Purchaser shall not have any duty of confidentiality or
duty not to trade in the securities of the Company to the Company or its subsidiaries after the issuance of the initial press release
as described in <U>Section 4.4</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
[RESERVED].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Exercise Procedures</U>. The form of Notice of Exercise included in the Common Warrants set forth the totality of the procedures required
of each Purchaser in order to exercise the Common Warrants. No additional legal opinion, other information or instructions shall be required
of each Purchaser to exercise its Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to
exercise the Common Warrants. The Company shall honor exercises of the Common Warrants and shall deliver Warrant Shares in accordance
with the terms, conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Lock-Up Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except
to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If
any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek
specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18
<U>Form D; Blue Sky Filings</U>. If applicable, the Company agrees to timely file a Form D with respect to the Securities as required
under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company
shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers
at the Closing under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence
of such actions (if any, depending on the Company&rsquo;s determination) promptly upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19
<U>Capital Changes</U>. From the date hereof until ninety (90) days after the Closing Date, the Company shall not undertake a reverse
or forward stock split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority
in interest of the Securities, except for any reverse or forward stock split or reclassification previously approved by the Company&rsquo;s
stockholders and expressly contemplated by the SEC Reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20
<U>SEC Filings; Registration Statement</U>. As soon as practicable, the Company shall file with the Commission (a) all reports, schedules,
forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant
to Section 13(a) or 15(d) thereof, and (b), if applicable, a Registration Statement on the applicable form pursuant to the terms of the
Registration Rights Agreement providing for the registration of the Securities, and in any event no later than fifteen (15) calendar
days of the date of this Agreement. The Company shall use commercially reasonable efforts to cause such Registration Statement to become
effective within 45 days following the date of the Registration Rights Agreement (or within 60 calendar days following the date of the
Registration Rights Agreement in the event of a &ldquo;limited review&rdquo; by the Commission of the Registration Statement or within
90 calendar days following the date of the Registration Rights Agreement in the event of a &ldquo;full review&rdquo; by the Commission
of the Registration Statement) and to keep such registration statement effective at all times until no Purchaser owns any Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21
<U>Stockholder Approval</U>. The Company shall hold a special meeting of stockholders at the earliest practicable date after the date
hereof, but in no event later than ninety (90) days after the Closing Date for the purpose of obtaining Stockholder Approval, if required
to effect the purpose thereof, with the recommendation of the Board that such proposal be approved, and the Company shall solicit proxies
from its stockholders in connection therewith in the same manner as all other management proposals in such proxy statement and all management-
appointed proxyholders shall vote their proxies in favor of such proposal. The Company shall use its reasonable best efforts to obtain
such Stockholder Approval, and request that its officers and directors, cast their proxies in favor of such proposal. If the Company
does not obtain Stockholder Approval at the first meeting, the Company shall call a meeting every ninety (90) days thereafter to seek
Stockholder Approval until the earlier of the date Stockholder Approval is obtained or the Warrants are no longer outstanding. Notwithstanding
the foregoing, the Company may, in lieu of holding a special meeting of stockholders as aforesaid, obtain the written consent of a majority
of its stockholders covering the Stockholder Approval so long as prior to forty five (45) days after the Closing Date, such written consents
are obtained and in accordance with Exchange Act Rule 14c-2 at least twenty (20) days shall have transpired from the date on which a
written information statement containing the information specified in Schedule 14C detailing such Stockholder Approval shall have been
filed with the SEC and delivered to stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by each Purchaser by written notice to the Company, if the Closing has not been
consummated on or before the fifth (5th) Trading Day following the date hereof; provided, however, that no such termination will affect
the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by the Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such
notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the
signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c)
the first (1st) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon
actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as
set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes,
or contains, material, non-public information regarding the Company or any subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and the Purchaser. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Each Purchaser may assign any or all of its rights under this Agreement to any Person to whom
each Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchaser.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third-party beneficiary of the representations and warranties of
the Company in <U>Section 3.1</U> and the representations and warranties of each Purchaser in <U>Section 3.2</U>. This Agreement is intended
for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any
provision hereof be enforced by, any other Person, except as otherwise set forth in <U>Section 4.8</U> and this <U>Section 5.8</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under <U>Section 4.8</U>, the prevailing party in such Action or Proceeding
shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary
damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents
and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at
law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to each Purchaser pursuant to any Transaction Document
or each Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchaser&rsquo;s Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through Blank Rome LLP, the legal counsel of the Placement Agent, and Blank Rome LLP, as legal counsel of
the Placement Agent, does not represent any of the Purchasers and only represents the Placement Agent The Company has elected to provide
all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested
to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each
other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively
and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLUCOTRACK,
                                            INC.</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301
                                            Rte. 17 North, Ste. 800</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rutherford,
    New Jersey 07070</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    pvgoode@glucotrack.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paul V. Goode</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy to (which shall not constitute notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nelson
Mullins Riley &amp; Scarborough LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301
Hillsborough St., Suite 1400</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raleigh,
North Carolina 27603</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
David Mannheim</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
david.mannheim@nelsonmullins.com</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: _______________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: _____________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile
Number of Authorized Signatory: __________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser: ___________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUB>&nbsp;</SUB></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Warrants to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $_____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrant Shares: ________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrant Shares: _____ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: ____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur by the first (1st) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated
by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any
agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be
an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or
the like or purchase price (as applicable) to such other party on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Common Warrant</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(See
attached)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Lock-Up Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(See
attached)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Pre-Funded Warrant</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(See
attached)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
D</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Registration Rights Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(See
attached)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 47; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTRATION
RIGHTS AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Registration Rights Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of December 29, 2025, between Glucotrack,
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser,
a &ldquo;<U>Purchaser</U>&rdquo; and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser
(the &ldquo;<U>Purchase Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and each Purchaser hereby agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Definitions</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capitalized
terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the
Purchase Agreement.</B> As used in this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Cutback
Registration Statement</U>&rdquo; shall have the meaning set forth in Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the closing of business, Eastern
Time, on the 45<SUP>th</SUP> calendar day following the date hereof (or, in the event of a &ldquo;limited review&rdquo; by the Commission,
the 60<SUP>th</SUP> calendar day following the date hereof or, in the event of a &ldquo;full review&rdquo; by the Commission, the 90<SUP>th</SUP>
calendar day following the date hereof) and with respect to any additional Registration Statements which may be required pursuant to
Section 2(c) or Section 3(c) (including any Cutback Registration Statement), the 45<SUP>th</SUP> calendar day following the date on which
an additional Registration Statement is required to be filed hereunder (or, in the event of a &ldquo;full review&rdquo; by the Commission,
the 60<SUP>th</SUP> calendar day following the date such additional Registration Statement is required to be filed hereunder); <U>provided</U>,
<U>however</U>, that in the event the Company is notified by the Commission that one or more of the above Registration Statements will
not be reviewed or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall
be the fifth Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise required above,
provided, further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next
succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, as soon as practicable following the date
hereof, and in any event, no later than the 15<SUP>th</SUP> calendar day following the date hereof and, with respect to any additional
Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the earliest practical date on which the Company
is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Plan
of Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the
Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all of the shares of Common Stock or shares of Common Stock underlying
the Pre-Funded Warrants (&ldquo;<U>Shares</U>&rdquo;) purchased pursuant to the Purchase Agreement, (b) all Warrant Shares then issued
and issuable upon exercise of the Warrants (assuming on such date the Warrants are exercised in full for cash without regard to any exercise
limitations therein) purchased pursuant to the Purchase Agreement, (d) any additional shares of Common Stock issued and issuable in connection
with any anti-dilution provisions in the Warrants (without giving effect to any limitations on exercise set forth in the Warrants) and
(e) any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with
respect to the foregoing; <U>provided, however</U>, that any such Registrable Securities shall cease to be Registrable Securities (and
the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect
thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by
the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective
Registration Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities
become eligible for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144
as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders
(assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which,
such securities were issued or are issuable, were at no time held by any Affiliate of the Company, and all Warrants are exercised by
&ldquo;cashless exercise&rdquo; as provided in Section 2(c) of each of the Warrants), as reasonably determined by the Company, upon the
advice of counsel to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
415</U>&rdquo; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Guidance</U>&rdquo; means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Registration
                                            Rights</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on
a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not
then eligible to register for resale the Registrable Securities on Form S-3 (which is the case as of the date hereof), in which case
such registration shall be on another appropriate form in accordance herewith, subject to the provisions of Section 2(e)) and shall contain
(unless otherwise directed by at least 85% in interest of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached
hereto as <U>Annex A</U> and substantially the &ldquo;<U>Selling Stockholder</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>,
<U>however</U>, that no Holder shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior
written consent. Subject to the terms of this Agreement, the Company shall use commercially reasonable efforts to cause a Registration
Statement filed under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under the Securities
Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use
commercially reasonable efforts to keep such Registration Statement continuously effective under the Securities Act until the date that
all Registrable Securities covered by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may
be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance
with the current public information requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion
letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;).
The Company shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading
Day. The Company shall immediately notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on
the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for
effectiveness of such Registration Statement. The Company shall, by 9:30 a.m. (New York City time) on the Trading Day after the effective
date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424. Failure to so notify the Holder
within one (1) Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an
Event under Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments
to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted
to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary
offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form; <U>provided</U>, <U>however</U>,
that prior to filing such amendment, the Company shall be obligated to use commercially reasonable efforts to advocate with the Commission
for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance
and Disclosure Interpretation 612.09.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding any other provision of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number of
Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding
that the Company used commercially reasonable efforts to advocate with the Commission for the registration of all or a greater portion
of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable
Securities to be registered on such Registration Statement will be reduced as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
                                            the Company shall reduce or eliminate any securities to be included other than Registrable
                                            Securities; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second,
                                            the Company shall reduce Registrable Securities represented by Warrant Shares (applied, in
                                            the case that some Warrant Shares may be registered, to the Holders on a pro rata basis based
                                            on the total number of unregistered Warrant Shares held by such Holders.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the
calculations as to such Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with
the foregoing, the Company will use its commercially reasonable efforts to file with the Commission, as promptly as allowed by Commission
or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or
such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration
Statement, as amended (the &ldquo;Cutback Registration Statement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration
Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the Company
shall be deemed to have not satisfied this clause (i)), or (ii) if the Cutback Registration Statement, if applicable, is not filed as
promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general or (iii) the Company
fails to file with the Commission a request for acceleration of a Registration Statement in accordance with Rule 461 promulgated by the
Commission pursuant to the Securities Act, within five Trading Days of the date that the Company is notified (orally or in writing, whichever
is earlier) by the Commission that such Registration Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further review,
or (iv) prior to the effective date of a Registration Statement, the Company fails to file a pre-effective amendment and otherwise respond
in writing to comments made by the Commission in respect of such Registration Statement within ten (10) calendar days after the receipt
of comments by or notice from the Commission that such amendment is required in order for such Registration Statement to be declared
effective, or (v) a Registration Statement (including the Initial Registration Statement or any Cutback Registration Statement) is not
declared effective by the Commission by the applicable Effectiveness Date, or (vi) after the effective date of a Registration Statement,
such Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included in such
Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities,
for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive
calendar days) during any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;, and for purposes
of clauses (i) and (v), the date on which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day
period is exceeded, and for purpose of clause (iv) the date which such ten (10) calendar day period is exceeded, and for purpose of clause
(vi) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred to as &ldquo;<U>Event
Date</U>&rdquo;), then, in addition to any other rights the Holders may have hereunder or under applicable law, on each such Event Date
and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable
Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to
the product of 1.5% multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the Purchase Agreement. The parties
agree that the maximum aggregate liquidated damages payable to a Holder under this Agreement shall be 10.5% of the aggregate Subscription
Amount paid by such Holder pursuant to the Purchase Agreement. If the Company fails to pay any partial liquidated damages pursuant to
this Section in full within seven days after the date payable, the Company will pay interest thereon at a rate of 18% per annum (or such
lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such partial liquidated
damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages pursuant to the
terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the
resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3
as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect
until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate
of a Holder as any Underwriter without the prior written consent of such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Registration
                                            Procedures</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&rsquo;s registration obligations hereunder, the Company shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to
the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is
notified of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed Selling Stockholder Notice and Questionnaire in the form attached to
this Agreement as <U>Annex C</U> (a &ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading
Days prior to the Filing Date or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives
draft materials in accordance with this Section. Each Holder shall provide any additional information as may be reasonably requested
by the Company and is necessary for purposes of complying with requirements under applicable securities laws and regulations or rules
of any applicable stock exchange where the Common Stock is then listed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to
register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to
the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such
Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied
by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible
(and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm
such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings
for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Use commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending
the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of
the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto
by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and
any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates or ook entry statements,
as applicable, representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates
shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities
to be in such denominations and registered in such names as any such Holder may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into
account the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. <FONT STYLE="text-decoration-style: double">If the Company notifies the Holders in accordance
with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus
have been made, then the Holders shall suspend use of such Prospectus. The Company will use commercially reasonable efforts to ensure
that the use of the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under
this Section 3(j) to suspend the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated
damages otherwise required pursuant to Section 2(d), for a period not to exceed 60 calendar days (which need not be consecutive days)
in any 12-month period</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any
supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing
if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
Acknowledging that the Company is not currently eligible to use Form S-3 for the registration of the resale of Registratble Securities,
the Company shall use commercially reasonable efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for
the registration of the resale of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock
beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control
over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of
the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s
request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Registration
                                            Expenses</U>. All fees and expenses incident to the performance of, or compliance with, this
                                            Agreement by the Company shall be borne by the Company whether or not any Registrable Securities
                                            are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing
                                            sentence shall include, without limitation, (i) all registration and filing fees (including,
                                            without limitation, fees and expenses of the Company&rsquo;s counsel and independent registered
                                            public accountants) (A) with respect to filings made with the Commission, (B) with respect
                                            to filings required to be made with any Trading Market on which the Common Stock is then
                                            listed for trading, and (C) in compliance with applicable state securities or Blue Sky laws
                                            reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements
                                            of counsel for the Company in connection with Blue Sky qualifications or exemptions of the
                                            Registrable Securities), (ii) printing expenses (including, without limitation, expenses
                                            of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery
                                            expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability
                                            insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other
                                            Persons retained by the Company in connection with the consummation of the transactions contemplated
                                            by this Agreement. In addition, the Company shall be responsible for all of its internal
                                            expenses incurred in connection with the consummation of the transactions contemplated by
                                            this Agreement (including, without limitation, all salaries and expenses of its officers
                                            and employees performing legal or accounting duties), the expense of any annual audit and
                                            the fees and expenses incurred in connection with the listing of the Registrable Securities
                                            on any securities exchange as required hereunder. In no event shall the Company be responsible
                                            for any broker or underwriter fees or commissions or similar commissions of any Holder or,
                                            except to the extent provided for in the Transaction Documents, any legal fees or other costs
                                            of the Holders.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Indemnification</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless
each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities
as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees
(and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any
other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with
a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such
controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities,
costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as
incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement,
any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading
or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any
rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but
only to the extent, that (i) such untrue or alleged untrue statements or omissions are based solely upon information regarding such Holder
furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such
Holder or such Holder&rsquo;s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing
by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood
that the Holder has approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified
in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has
notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior
to the receipt by such Holder of the Advice contemplated in Section 6(c). The Company shall notify the Holders promptly of the institution,
threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the
Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified
person and shall survive the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(f).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Indemnification by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue or alleged untrue statement or
omission is contained in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration
Statement or such Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information
provided in the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and
expressly approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved
Annex A hereto for this purpose), such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling
Holder be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim
relating to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement
or omission) received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to
such indemnification obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such
Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to
any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to
the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent
such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing
that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to
assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying
Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which
consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified
Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section)
shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided
that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such
actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject
to appeal or further review) not to be entitled to indemnification hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Contribution</U>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold
an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified
Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative
fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in
question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has
been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative
intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or
payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any
reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party
would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party
in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately
preceding paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the
dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the
amount of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have
to the Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Miscellaneous</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Remedies</U>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and
each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it
of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect
of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of its security
holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements
other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities
are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) shall
not prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement so long as no new
securities are registered on any such existing registration statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from
the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company
agrees and acknowledges that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities
hereunder shall be subject to the provisions of Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified
or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing
and signed by the Company and the Holders of 67% or more of the then outstanding Registrable Securities (for purposes of clarification,
this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification
or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder
(or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to
a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each
Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities
shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof
with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly
affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver
or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented
except in accordance with the provisions of the first sentence of this Section 6(d). No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered
to all of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered
as set forth in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign
their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>No Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the
Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Except as set forth on <U>Schedule 6(i)</U>, neither the Company nor any of its Subsidiaries has previously entered into any
agreement granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Execution and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall
be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile
or &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
determined in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Headings</U>. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be
deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Independent Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint
with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture
or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity
with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges
that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out
of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such
purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company,
not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested
to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company
and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>GLUCOTRACK,
                    INC.</B></FONT></P>

</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    V. Goode</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE OF HOLDERS FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Plan
of Distribution</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Selling Stockholder (together, the &ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees
and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the [principal Trading Market
or any other stock exchange, market or trading facility on which the securities are traded or in private transactions]. These sales may
be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
                                            brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
                                            trades in which the broker-dealer will attempt to sell the securities as agent but may position
                                            and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
                                            by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
                                            negotiated transactions;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
                                            of short sales;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            transactions through broker-dealers that agree with the Selling Stockholders to sell a specified
                                            number of such securities at a stipulated price per security;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
                                            the writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            combination of any such methods of sale; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other method permitted pursuant to applicable law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933,
as amended (the &ldquo;<U>Securities Act</U>&rdquo;), if available, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or
markdown in compliance with FINRA Rule 2121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company
has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar
effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule
of similar effect. The securities covered hereby will be sold only through registered or licensed brokers or dealers if required under
applicable state securities laws. In addition, in certain states, the securities covered hereby may not be sold unless they have been
registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available
and is complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the securities may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the
securities by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders
and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common stock being offered by the selling stockholders are those previously issued to the selling stockholders, and those issuable to
the selling stockholders, upon exercise of the warrants. For additional information regarding the issuances of those shares of common
stock and warrants, see &ldquo;Private Placement of Shares of Common Stock and Warrants&rdquo; above. We are registering the shares of
common stock in order to permit the selling stockholders to offer the shares for resale from time to time. Except for the ownership of
the shares of common stock and the warrants, the selling stockholders have not had any material relationship with us within the past
three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of common stock by
each of the selling stockholders. The second column lists the number of shares of common stock beneficially owned by each selling Stockholder,
based on its ownership of the shares of common stock and warrants, as of ________, 2025, assuming exercise of the warrants held by the
selling stockholders on that date, without regard to any limitations on exercises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of common stock being offered by this prospectus by the selling stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the selling stockholders, this prospectus generally covers the resale
of the sum of (i) the number of shares of common stock issued to the selling stockholders in the &ldquo;Private Placement of Shares of
Common Stock and Warrants&rdquo; described above and (ii) the maximum number of shares of common stock issuable upon exercise of the
related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date
this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of
determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the
exercise of the warrants. The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this
prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the warrants [and other warrants held by selling stockholders], a selling Stockholder may not exercise [the] [any such]
warrants to the extent such exercise would cause such selling Stockholder, together with its affiliates and attribution parties, to beneficially
own a number of shares of common stock which would exceed 4.99% or 9.99%, as applicable, of our then outstanding common stock following
such exercise, excluding for purposes of such determination shares of common stock issuable upon exercise of such warrants which have
not been exercised. The number of shares in the second and fourth columns do not reflect this limitation. The selling stockholders may
sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name of Selling
    Stockholder</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: justify; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                                                                of Shares <BR> of Common Stock</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owned
                                            Prior to Offering</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum<BR>

                                            Number of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
                                            of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
                                                              Stock to</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>be
                                            Offered Pursuant</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to
                                            this</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: justify; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                                                                of Shares <BR> of Common Stock</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owned
                                            After Offering</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Percent</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Percent</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%"></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">GLUCOTRACK,
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
Stockholder Notice and Questionnaire</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Glucotrack, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), understands that the Company has filed or intends to file with the Securities and Exchange Commission
(the &ldquo;<U>Commission</U>&rdquo;) a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration
and resale under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities,
in accordance with the terms of the Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this
document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth
below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences
of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable
Securities owned by it in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUESTIONNAIRE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
                                            Legal Name of Selling Stockholder</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 86%; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
                                            Legal Name of Registered Holder (if not the same as (a) above) through which Registrable
                                            Securities are held:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 86%; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
                                            Legal Name of Natural Control Person (which means a natural person who directly or indirectly
                                            alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 86%; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Address
                                            for Notices to Selling Stockholder:</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT>
    <FONT STYLE="font-family: Times New Roman, Times, Serif">______________________________________________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
    ____________________________________________________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
    Person: ___________________________________________________________________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Broker-Dealer
                                            Status:</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                            you a broker-dealer?</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities as compensation
                                            for investment banking services to the Company?</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            &ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s staff has indicated that you should
                                            be identified as an underwriter in the Registration Statement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                            you an affiliate of a broker-dealer?</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable
                                            Securities in the ordinary course of business, and at the time of the purchase of the Registrable
                                            Securities to be resold, you had no agreements or understandings, directly or indirectly,
                                            with any person to distribute the Registrable Securities?</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s staff has indicated that you should
                                            be identified as an underwriter in the Registration Statement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficial
                                            Ownership of Securities of the Company Owned by the Selling Stockholder.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than
the securities issuable pursuant to the Purchase Agreement.</I></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
                                            and Amount of other securities beneficially owned by the Selling Stockholder:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 86%; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relationships
                                            with the Company:</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5%
of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with
the Company (or its predecessors or affiliates) during the past three years.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
any exceptions here:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 86%; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may
occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall
not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment
of the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either
in person or by its duly authorized agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: _________________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial Owner: __________________________________</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
FAX A COPY (OR EMAIL A .PDF COPY) OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">_____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">_____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">_____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>ex10-3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
29, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Curvature
Securities LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39
Main Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chatham,
New Jersey 07928</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:
Glucotrack, Inc.&mdash;Proposed Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that you (&ldquo;<B><I>Curvature Securities</I></B>&rdquo; or the &ldquo;<B><I>Placement Agent</I></B>&rdquo;)
propose to enter into or has entered into a Placement Agency Agreement (the &ldquo;<B><I>Placement Agency Agreement</I></B>&rdquo;) providing
for the offer and sale (the &ldquo;<B><I>Offering</I></B>&rdquo;) of (i) shares of common stock, par value $0.001 per share (the &ldquo;<B><I>Common
Stock</I></B>&rdquo;), of Glucotrack, Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), (ii) warrants to purchase
shares of Common Stock (the &ldquo;<B><I>Common Warrants</I></B>&rdquo;), and (iii) pre-funded warrants to purchase shares of Common
Stock (the &ldquo;<B><I>Pre-Funded Warrants</I></B>&rdquo;, and together with the Common Warrants, the &ldquo;<B><I>Warrants</I></B>,&rdquo;
and collectively with the Common Stock, the &ldquo;<B><I>Securities</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the execution of the Placement Agency Agreement by Curvature Securities, and for other good and valuable consideration,
the undersigned hereby irrevocably agrees that, without the prior written consent of Curvature Securities, the undersigned will not,
directly or indirectly, (a) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is
designed to, or could reasonably be expected to, result in the transfer or disposition by any person at any time in the future of) any
shares of Common Stock (including, without limitation, shares of Common Stock that may be deemed to be beneficially owned by the undersigned
in accordance with the rules and regulations of the Securities and Exchange Commission and shares of Common Stock that may be issued
upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for Common Stock; (b) enter into
any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership
of shares of Common Stock, whether any such transaction described in clause (a) or (b) above is to be settled by delivery of Common Stock
or other securities, in cash or otherwise; (c) except as provided for below, make any demand for or exercise any right or cause to be
filed a registration statement, including any amendments thereto, with respect to the registration of any shares of Common Stock or securities
convertible into or exercisable or exchangeable for Common Stock or any other securities of the Company; or (d) publicly disclose the
intention to do any of the foregoing for a period commencing on the date hereof and ending ninety (90) days after the date of the effective
date of this Agreement (such 90-day period, the &ldquo;<B><I>Lock-Up Period</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing paragraph shall not apply to (a) transactions relating to shares of Common Stock or other securities acquired in the open market
after the completion of the Offering; (b) bona fide gifts of shares of Common Stock or any security convertible into Common Stock, in
each case that are made exclusively between and among the undersigned or members of the undersigned&rsquo;s family, or affiliates of
the undersigned, including its partners (if a partnership) or members (if a limited liability company); (c) any transfer of shares of
Common Stock or any security convertible into Common Stock by will or intestate succession upon the death of the undersigned; (d) transfer
of shares of Common Stock or any security convertible into Common Stock to an immediate family member (for purposes of this Lock-Up Letter
Agreement, &ldquo;<B>immediate family</B>&rdquo; shall mean any relationship by blood, marriage or adoption, not more remote than first
cousin) or any trust, limited partnership, limited liability company or other entity for the direct or indirect benefit of the undersigned
or any immediate family member of the undersigned; <I>provided </I>that, in the case of clauses (b), (c) and (d) above, it shall be a
condition to any such transfer that (i) the transferee/donee agrees to be bound by the terms of this Lock-Up Letter Agreement (including,
without limitation, the restrictions set forth in the preceding sentence) to the same extent as if the transferee/donee were a party
hereto; (ii) each party (donor, donee, transferor or transferee) shall not be required by law (including without limitation the disclosure
requirements of the Securities Act of 1933, as amended (the &ldquo;<B><I>Securities Act</I></B>&rdquo;), and the Securities Exchange
Act of 1934, as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;)) to make, and shall agree to not voluntarily make, any filing
or public announcement of the transfer or disposition prior to the expiration of the 90-day period referred to above; and (iii) the undersigned
notifies Curvature Securities at least two (2) business days prior to the proposed transfer or disposition; (e) the transfer of shares
to the Company to satisfy withholding obligations for any equity award granted pursuant to the terms of the Company&rsquo;s stock option/incentive
plans, such as upon exercise, vesting, lapse of substantial risk of forfeiture, or other similar taxable event, in each case on a &ldquo;cashless&rdquo;
or &ldquo;net exercise&rdquo; basis (which, for the avoidance of doubt shall not include &ldquo;cashless&rdquo; exercise programs involving
a broker or other third party), <I>provided</I> that as a condition of any transfer pursuant to this clause (e), that if the undersigned
is required to file a report under Section 16(a) of the Exchange Act, reporting a reduction in beneficial ownership of shares of Common
Stock or any securities convertible into or exercisable or exchangeable for Common Stock during the Lock-Up Period, the undersigned shall
include a statement in such report, and if applicable an appropriate disposition transaction code, to the effect that such transfer is
being made as a share delivery or forfeiture in connection with a net value exercise, or as a forfeiture or sale of shares solely to
cover required tax withholding, as the case may be; (f) transfers of shares of Common Stock or any security convertible into or exercisable
or exchangeable for Common Stock pursuant to a bona fide third party tender offer made to all holders of the Common Stock, merger, consolidation
or other similar transaction involving a change of control (as defined below) of the Company, including voting in favor of any such transaction
or taking any other action in connection with such transaction, <I>provided</I> that in the event that such merger, tender offer or other
transaction is not completed, the Common Stock and any security convertible into or exercisable or exchangeable for Common Stock shall
remain subject to the restrictions set forth herein; (g) the vesting of equity awards, the exercise of warrants or the exercise of stock
options granted pursuant to the Company&rsquo;s stock option/incentive plans or otherwise outstanding on the date hereof; <I>provided</I>,
that the restrictions shall apply to shares of Common Stock issued upon such vesting, exercise or conversion; (h) the establishment of
any, or the continued use of any existing, contract, instruction or plan that satisfies all of the requirements of Rule 10b5-1 (a &ldquo;<B><I>Rule
10b5-1 Plan</I></B>&rdquo;) under the Exchange Act; <I>provided</I>, <I>however</I>, that except for already existing plans, no sales
of Common Stock or securities convertible into, or exchangeable or exercisable for, Common Stock, shall be made pursuant to a Rule 10b5-1
Plan prior to the expiration of the Lock-Up Period; <I>provided further</I>, that the Company is not required to report the establishment
of such Rule 10b5-1 Plan in any public report or filing with the Commission under the Exchange Act during the lock-up period and does
not otherwise voluntarily effect any such public filing or report regarding such Rule 10b5-1 Plan; and (i) any demands or requests for,
exercise any right with respect to, or take any action in preparation of, the registration by the Company under the Securities Act of
the undersigned&rsquo;s shares of Common Stock, provided that no transfer of the undersigned&rsquo;s shares of Common Stock registered
pursuant to the exercise of any such right and no registration statement shall be filed under the Securities Act with respect to any
of the undersigned&rsquo;s shares of Common Stock during the Lock-Up Period. For purposes of clause (f) above, &ldquo;<B>change of control</B>&rdquo;
shall mean the consummation of any bona fide third party tender offer, merger, purchase, consolidation or other similar transaction the
result of which is that any &ldquo;<B>person</B>&rdquo; (as defined in Section 13(d)(3) of the Exchange Act), or group of persons, becomes
the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of a majority of total voting power of the voting stock
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned also agrees and consents to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar
against the transfer of the undersigned&rsquo;s securities subject to this Lock-Up Letter Agreement except in compliance with this Lock-Up
Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is understood that, if the Company notifies Curvature Securities that it does not intend to proceed with the Offering, if the Placement
Agency Agreement does not become effective, or if the Placement Agency Agreement (other than the provisions thereof which survive termination)
shall terminate or be terminated prior to payment for and delivery of the Securities, the undersigned will be released from its obligations
under this Lock-Up Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that the Company and Curvature Securities will proceed with the Offering in reliance on this Lock-Up Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Lock-Up Letter Agreement shall automatically terminate upon (a) the termination of the Placement Agency Agreement prior to the issuance
and delivery of the Securities, (b) the date that either the Company or Curvature Securities provides written notice to the other that
it has determined not to proceed with the proposed Offering and, with respect to the Company, is terminating this Lock-Up Letter Agreement
on behalf of all of the Company&rsquo;s holders of securities subject to a Lock-Up Letter Agreement, provided that the Company and Curvature
Securities shall not have executed the Placement Agency Agreement on or prior to such date. Notwithstanding anything herein to the contrary,
this Lock-Up Letter Agreement shall lapse and become null and void if the closing of the Offering shall not have occurred on or before
January 31, 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned acknowledges that the execution, delivery and performance of this Lock-Up Agreement is also material inducement to each Purchaser
(as defined in the Securities Purchase Agreement entered into by the Company and each Purchaser named therein connection with the purchase
of the Securities (the &ldquo;<B><I>Purchase Agreement</I></B>&rdquo;) to complete the transactions contemplated by the Purchase Agreement
and that the Company shall be entitled to specific performance of the undersigned&rsquo;s obligations hereunder. The undersigned hereby
represents that the undersigned has the power and authority to execute, deliver and perform this Lock-Up Agreement, that the undersigned
has received adequate consideration therefor and that the undersigned will indirectly benefit from the closing of the transactions contemplated
by the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands and agrees that this Lock-Up Agreement is irrevocable and shall be binding upon the undersigned&rsquo;s heirs,
legal representatives, successors, and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Lock-Up Letter Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the
conflict of laws principles thereof. Delivery of a signed copy of this Lock-Up Letter Agreement by facsimile or e-mail/.pdf transmission
shall be effective as the delivery of the original hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Letter Agreement
and that, upon request, the undersigned will execute any additional documents necessary in connection with the enforcement hereof. Any
obligations of the undersigned shall be binding upon the heirs, personal representative, successors and assigns of the undersigned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
page follows]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">(Name of Signatory, in the case of entities &ndash; Please Print)</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">(Title of Signatory, in the case of entities &ndash; Please Print)</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>8
<FILENAME>ex10-4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Curvature
Securities LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>39
Main Street<BR>
Chatham, NJ 07928</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
29, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glucotrack,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301
Route 17 North, Suite 800</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rutherford,
NJ 07070</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Paul Goode</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Placement Agency Agreement</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Goode:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of this letter agreement (the &ldquo;<B>Agreement</B>&rdquo;) between Curvature Securities LLC, as the sole
placement agent (&ldquo;<B>Curvature</B>&rdquo;) (Curvature is also referred to herein as the &ldquo;<B>Placement Agent</B>&rdquo;),
and Glucotrack, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), the parties hereby agree that the Placement Agent shall
serve as the placement agent for the Company, on a &ldquo;reasonable best efforts&rdquo; basis, in connection with the proposed placement
(the &ldquo;<B>Placement</B>&rdquo;) of securities of the Company, consisting of: (i) shares of the Company&rsquo;s common stock, par
value $0.001 per share (&ldquo;<B>Common Stock</B>&rdquo;); and (ii) warrants to purchase Common Stock (the &ldquo;<B>Common Warrants</B>&rdquo;);
and (iii) Pre-Funded warrants to purchase shares of Common Stock (the &ldquo;<B>Pre-Funded Warrants</B>&rdquo;, and together with the
Common Warrants, the &ldquo;<B>Warrants</B>&rdquo;). The Common Stock and Warrants actually placed by the Placement Agent are referred
to herein as the &ldquo;<B>Placement Agent Securities</B>.&rdquo; The documents executed and delivered by the Company and the Purchasers
(as defined below) in connection with the Placement, including, without limitation, a securities purchase agreement (the &ldquo;<B>Purchase
Agreement</B>&rdquo;), shall be collectively referred to herein as the &ldquo;<B>Transaction Documents</B>.&rdquo; The terms of the Placement
shall be mutually agreed upon by the Company and the purchasers listed in the Purchase Agreement (each, a &ldquo;<B>Purchaser</B>&rdquo;
and collectively, the &ldquo;<B>Purchasers</B>&rdquo;), and nothing herein constitutes that the Placement Agent would have the power
or authority to bind the Company or any Purchaser, or an obligation for the Company to issue any Placement Agent Securities or complete
the Placement. The Company expressly acknowledges and agrees that the Placement Agent&rsquo;s obligations hereunder are on a reasonable
best efforts basis only and that the execution of this Agreement does not constitute a commitment by the Placement Agent to purchase
the Placement Agent Securities and does not ensure the successful placement of the Placement Agent Securities or any portion thereof
or the success of the Placement Agent with respect to securing any other financing on behalf of the Company. The Securities shall be
offered and sold in a private placement. The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers
on its behalf in connection with the Placement, subject to the prior written approval in each case of the Company. Certain affiliates
of the Placement Agent may participate in the Placement by purchasing some of the Placement Agent Securities. The sale of Placement Agent
Securities to any Purchaser will be evidenced by the Purchase Agreement between the Company and such Purchaser, in a form reasonably
acceptable to the Company and the Purchaser. Capitalized terms that are not otherwise defined herein have the meanings given to such
terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers of the Company will be available to answer
inquiries from prospective Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Representations and Warranties of the Company; Covenants of the Company</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Representations of the Company</U>. With respect to the Placement Agent Securities, each of the representations and warranties (together
with any related disclosure schedules thereto) and covenants made by the Company to the Purchasers in the Purchase Agreement in connection
with the Placement, is hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of the
date of this Agreement and as of the Closing Date, hereby made to, and in favor of, the Placement Agent. Furthermore, the Placement Agent
Warrants (as defined below) have been duly authorized, and when executed and delivered by the Company, shall constitute a valid, legal
and binding obligation of the Company, enforceable in accordance with their terms, except as such enforceability may be limited by bankruptcy,
insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general principles of equity. In
addition to the foregoing, the Company represents and warrants that there are no affiliations with any Financial Industry Regulatory
Authority (&ldquo;<B>FINRA</B>&rdquo;) member firm participating in the Placement among the Company&rsquo;s officers, directors or, to
the knowledge of the Company, any five percent (5.0%) or greater stockholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Covenants of the Company</U>. The Company covenants and agrees to continue to retain (i) a firm of Public Company Accounting Oversight
Board independent registered public accountants for a period of at least two (2) years after the Closing Date and (ii) a competent transfer
agent for a period of two (2) years after the Closing Date, provided the Company is then subject to the reporting requirement of the
Exchange Act (as defined below). Furthermore, until sixty (60) days after the Effectiveness Date (as defined in the Purchase Agreement),
neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance
of any shares of Common Stock or Common Stock Equivalents, or (ii) file any registration statement or amendment or supplement thereto,
other than a Registration Statement pursuant to the Registration Rights Agreement or filing a registration statement on Form S-8 in connection
with any employee benefit plan. In addition, from the date hereof until twelve (12) months after the Effectiveness Date, the Company
shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of
Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction (as defined in the
Purchase Agreement); <U>provided</U>, <U>however</U>, that (A) commencing sixty (60) days after the Effectiveness Date, the Company&rsquo;s
issuance of Common Stock or Common Stock Equivalents pursuant to an &ldquo;at the market offering&rdquo; facility with the Placement
Agent as sales agent shall not be deemed a Variable Rate Transaction; and (B) sales of the Company&rsquo;s securities beginning sixty
(60) days after the Effectiveness Date pursuant to the ELOC (as defined below) shall not be deemed a Variable Rate Transaction. The Company
entered into a Purchase Agreement dated September 11, 2025 with Sixth Borough Capital Fund, LP to sell securities pursuant to an equity
line of credit (the &ldquo;<U>ELOC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Representations of the Placement Agent</U>. The Placement Agent represents and warrants that it (i) is a member in good standing of
the FINRA, (ii) is registered as a broker/dealer under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;),
(iii) is licensed as a broker/dealer under the laws of the United States of America, applicable to the offers and sales of the Placement
Agent Securities by the Placement Agent, (iv) is and will be a corporate body validly existing under the laws of its place of incorporation,
and (v) has full power and authority to enter into and perform its obligations under this Agreement. The Placement Agent will immediately
notify the Company in writing of any change in its status with respect to subsections (i) through (v) above. The Placement Agent covenants
that it will use its reasonable best efforts to conduct the Placement hereunder in compliance with the provisions of this Agreement and
the requirements of applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Compensation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent and/or its respective designees
a cash fee of 7.00% of the aggregate purchase price paid by any and all Purchasers at the Closing. The Cash Fee shall be paid at the
closing of the Offering (the &ldquo;<B>Closing</B>&rdquo;) from the gross proceeds of the Placement Agency Securities sold. The Placement
Agent reserves the right to reduce any item of compensation or adjust the terms thereof as specified herein in the event that a determination
is made by FINRA to the effect that the Placement Agent&rsquo;s aggregate compensation is in excess of that permitted by FINRA Rules
or that the terms thereof require adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company further agrees to issue to the Placement Agent and/or its designees on the Closing Date, warrants to purchase such number
of Common Stock equal to four percent (4%) of the aggregate number of Placement Agent Securities issued at the Closing (the &ldquo;<B>Placement
Agent&rsquo;s Warrants</B>&rdquo;). The Placement Agent&rsquo;s Warrants shall be exercisable on and after the date that is one hundred
eighty (180) days from the date of commencement of sales of this offering and will terminate on the earlier of (x) the termination date
of the Common Warrants and (y) five (5) years from the date of commencement of sales of this offering. The exercise price of the Placement
Agent&rsquo;s Warrants shall be 110% of the offering price of one share of the Common Stock or Pre-Funded Warrant with a Common Warrant.
The Placement Agent&rsquo;s Warrants and the shares of Common Stock issuable upon exercise of the Placement Agent&rsquo;s Warrants (collectively
&ldquo;<B>Compensation Securities</B>&rdquo;) will be deemed compensation by FINRA, and therefore will be subject to FINRA Rule 5110(e)(1).
In accordance with FINRA Rule 5110(e)(1), neither the Placement Agent&rsquo;s Warrants nor any of the shares of Common Stock issued upon
exercise of the Placement Agent&rsquo;s Warrants may be sold, transferred, assigned, pledged or hypothecated, or be the subject of any
hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities by
any person, for a period of 180 days beginning on the date of commencement of sales of the public equity offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Placement Agent shall be entitled to compensation with respect to any public or private offering or other financing or capital-raising
transaction of any kind including any inducement transaction (each, a &ldquo;<B>Tail Financing</B>&rdquo;), to the extent such financing
is (i) provided to the Company by investors placed in the Offering by the Placement Agent, taken Over-The-Wall (&ldquo;<B>OTW</B>&rdquo;)
by the Placement Agent, or that participated in meetings with the Company arranged by the Placement Agent and (ii) such Tail Financing
is consummated at any time within the twelve (12) month period following the Termination Date. The Placement Agent&rsquo;s compensation
on Tail Financings shall be subject to the Cash Fee, and the Placement Agent&rsquo;s Warrants, as defined above. The Placement Agent
will deliver a list of all investors from which future investments would qualify under a Tail Financing at termination or Closing. Notwithstanding
the foregoing, no fee shall be payable by the Company pursuant to this Section 3.C. if the Company terminates this Agreement for cause
pursuant to FINRA Rule 5110(g)(5)(B).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Expenses</U>. The Company also agrees to reimburse the Placement Agent for reasonable and documented out-of-pocket accountable legal
expenses incurred by the Placement Agent in connection with the transaction in the amount of up to $75,000 as well as non-accountable
expenses (the &ldquo;<B>NAE</B>&rdquo;) including, but not limited to, background check(s), tombstones, marketing related expenses; i.e.
roadshow, travel, et al. and any other expenses incurred by the Placement Agent in connection with the transaction, (provided, however,
that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement). In the
event that private placement or registered direct offering documents are prepared and negotiated but the transaction that is consummated
is a follow-on-public offering, then the legal fees to be reimbursed by the Company shall be increased to $150,000. The Company&rsquo;s
obligation to reimburse the Placement Agent for accountable legal expenses and non-accountable expenses is contingent upon the successful
Closing of the Offering and such reimbursements shall be paid solely from the proceeds of the Offering simultaneously with the Closing.
The total NAE allowance shall not exceed $25,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
To the extent permitted by law, with respect to the Placement Agent Securities, the Company shall indemnify the Placement Agent and its
affiliates, agents, stockholders, directors, officers, employees, members and controlling persons (within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act) (each such entity or person, an &ldquo;<B>Indemnified Person</B>&rdquo;) from and
against all claims, actions, suits, proceedings (including those of stockholders), damages, costs and liabilities (collectively, &ldquo;<B>Claims</B>&rdquo;),
and shall reimburse each Indemnified Person for all reasonable fees and expenses (including the reasonable fees and expenses of counsel)
(collectively, the &ldquo;<B>Expenses</B>&rdquo;) as they are incurred by an Indemnified Person in investigating, preparing, pursuing
or defending any Claim, whether or not an Indemnified Person is a party thereto, that is caused by, arises out of, or is based upon,
any actions taken or omitted to be taken by the Company or any Indemnified Person in connection with this Agreement; provided, however,
the Company will not be responsible for any Claims or Expenses of any Indemnified Person that are determined to have resulted directly
from such Indemnified Person&rsquo;s (x) willful misconduct, violation of law or gross negligence in connection with any of the action,
inaction or the services described herein, or (y) use of any offering materials or information concerning the Company in connection with
the offer or sale of the Placement Agent&rsquo;s Securities in the Placement, which were not authorized for such use by the Company and
which use constitutes gross negligence, violation of law or willful misconduct. In no event shall the Company or any Indemnified Person
be responsible for any special, indirect or consequential damages incurred by the other.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Promptly after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to
which any Indemnified Person is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim
or of the commencement of such action or proceeding, but failure to so notify the Company shall not relieve the Company from any obligation
it may have hereunder, except and only to the extent such failure results in the forfeiture by the Company of substantial rights and
defenses. If the Company so elects or is requested by the Placement Agent, the Company will assume the defense of such action or proceeding
and will employ counsel reasonably satisfactory to the Placement Agent and will pay the reasonable fees and expenses of such counsel.
Notwithstanding the preceding sentence, the Placement Agent will be entitled to employ its own counsel separate from counsel for the
Company and from any other party in such action if counsel for the Placement Agent reasonably determines that it would be inappropriate
under the applicable rules of professional responsibility for the same counsel to represent both the Company and the Placement Agent.
In such event, the reasonable fees and disbursements of no more than one such separate counsel will be paid by the Company, in addition
to fees of local counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company may not settle, compromise or consent to the entry of any judgment in any pending or threatened Claim, in which indemnification
may be sought hereunder (whether or not any Indemnified Person is an actual or potential party thereto), without the prior written consent
of the Placement Agent (which will not be unreasonably delayed or withheld) unless such settlement, compromise or consent provides for
an unconditional and irrevocable release of each Indemnified Person from any and all liability arising out of such Claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any Claim or the commencement
of any action or proceeding relating to a transaction contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless,
then the Company shall contribute to the amount paid or payable by the Placement Agent as a result of such Claim or Expenses in such
proportion as is appropriate to reflect (a) the relative benefits to the Company on the one hand, and the Placement Agent on the other
hand, in connection with the Placement, (b) the relative fault of the parties, and (c) other equitable considerations; provided, however,
that in no event shall the amount to be contributed by the Placement Agent exceed the fees actually received, or to be received, by the
Placement Agent under this Agreement. Notwithstanding the immediately preceding sentence, to the extent the exception to indemnification
contemplated by Paragraph A of this Section applies with respect to the Placement Agent, the Company shall contribute to the amount paid
or payable by the Placement Agent as a result of such Claim or Expenses in such proportion as is appropriate to reflect the relative
fault of the Company, on the one hand, and the Placement Agent, on the other hand, in connection with the matters contemplated by the
Agreement. The Company agrees that for the purposes of this paragraph the relative benefits to the Company and the Placement Agent of
the contemplated transaction (whether or not such transaction is consummated) shall be deemed to be in the same proportion that the aggregate
cash consideration payable (or contemplated to be payable) in such transaction bears to the fees paid or payable to the Placement Agent
under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
These indemnification provisions shall remain in full force and effect whether or not the transaction contemplated by this Agreement
is completed, survive the termination of this Agreement, and be in addition to any liability that the Company might otherwise have to
any Indemnified Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Engagement Term</U>. The Placement Agent&rsquo;s engagement hereunder will be until the earlier of the Closing Date and March 22,
2026. The date of termination of this Agreement is referred to herein as the &ldquo;<B>Termination Date</B>.&rdquo; In the event, however,
in the course of the Placement Agent&rsquo;s performance of due diligence it deems it necessary to terminate the engagement, the Placement
Agent may do so prior to the Termination Date. The Company may elect to terminate the engagement hereunder for any reason prior to the
Termination Date but will remain responsible for fees pursuant to Section 3 hereof with respect to the Placement Agent Securities if
sold in the Placement. Notwithstanding anything to the contrary contained herein, the provisions concerning the Company&rsquo;s obligation
to pay any fees actually earned pursuant to Section 3 hereof and the provisions concerning confidentiality, indemnification and contribution
contained herein, as well as provisions in Sections 10 &ndash; 14 hereof will survive any expiration or termination of this Agreement.
If this Agreement is terminated prior to the completion of the Placement, all fees and expenses due to the Placement Agent as set forth
in Section 3 and Section 4 shall be paid by the Company to the Placement Agent on or before the Termination Date (in the event such fees
are earned or owed as of the Termination Date). The Placement Agent agrees not to use any confidential information concerning the Company
provided to the Placement Agent by the Company for any purposes other than those contemplated under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Placement Agent Information</U>. The Company agrees that any information or advice rendered by the Placement Agent in connection with
this engagement is for the confidential use of the Company only in its evaluation of the Placement and, except as otherwise required
by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s
prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>No Fiduciary Relationship</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person
or entity not a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company acknowledges
and agrees that the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities
to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement
Agent hereunder, all of which are hereby expressly waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Closing</U>. The obligations of the Placement Agent, and the closing of the sale of the Placement Agent Securities hereunder are subject
to the accuracy, when made and on the Closing Date, of the representations and warranties on the part of the Company contained herein
and in the Purchase Agreement, to the performance by the Company of its obligations hereunder and in the Purchase Agreement, and to each
of the following additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this
Agreement, the Placement Agent Securities, and all other legal matters relating to this Agreement and the transactions contemplated hereby
with respect to the Placement Agent Securities shall be reasonably satisfactory in all material respects to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Placement Agent shall have received from the Company&rsquo;s counsel, Nelson Mullins Riley &amp; Scarborough LLP, such counsel&rsquo;s
written opinion and negative assurance statement with respect to the Placement Agent Securities, addressed to the Placement Agent and
the Purchasers and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
[Reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Shares of Common Stock sold in the Placement, including shares of Common Stock issuable upon the exercise of the Warrants, must be registered
under the Exchange Act. The Company shall have taken no action designed to, or likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market or other
applicable U.S. national exchange, nor has the Company received any information suggesting that the Securities and Exchange Commission
or the Trading Market or other U.S. applicable national exchange is contemplating terminating such registration or listing, except as
otherwise publicly disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Placement Agent Securities or materially and
adversely affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order
or order of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which
would prevent the issuance or sale of the Placement Agent Securities or materially and adversely affect or potentially and adversely
affect the business or operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Company shall have entered into a Purchase Agreement with each of the Purchasers of the Placement Agent Securities and such agreements
shall be in full force and effect and shall contain representations, warranties and covenants of the Company as agreed upon between the
Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition,
the Company shall, if requested by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s
behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and pay all
filing fees required in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
The Placement Agent shall have received customary certificates of the Company&rsquo;s executive officers, as to the accuracy of the representations
and warranties contained in the Purchase Agreement, a certificate of the Company&rsquo;s Chief Financial Officer in a form reasonably
acceptable to the Placement Agent, and a certificate of the Company&rsquo;s secretary certifying (i) that the Company&rsquo;s charter
documents are true and complete, have not been modified and are in full force and effect; (ii) that the resolutions of the Company&rsquo;s
Board of Directors relating to the Placement are in full force and effect and have not been modified; and (iii) as to the incumbency
of the officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Placement Agent shall have received an executed lock-up agreement from each of the Company&rsquo;s executive officers and directors
prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the conditions specified in this Section 9 shall not have been fulfilled when and as required by this Agreement, all obligations
of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the Closing Date. Notice of such
cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Governing Law</U>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable
to agreements made and to be performed entirely in such State, without regard to principles of conflicts of law. This Agreement may not
be assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the
benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any
dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement
may be brought into the courts of the State of New York or into the Federal Court located in New York, New York and, by execution and
delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the
jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the
prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney&rsquo;s fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>Entire Agreement/Miscellaneous</U>. This Agreement embodies the entire agreement and understanding between the parties hereto, and
supersedes all prior agreements and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined
to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision
of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except
by an instrument in writing signed by both the Placement Agent and the Company. The representations, warranties, agreements and covenants
contained herein shall survive the Closing Date of the Placement and delivery of the Placement Agent Securities for the applicable statute
of limitations. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent
to the email address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b)
the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature pages
attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business
day following the date of mailing, if sent by an internationally recognized air courier service, or (d) upon actual receipt by the party
to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>Press Announcements</U>. The Company agrees that the Placement Agent shall, on and after the Closing Date, have the right to reference
the Placement and the Placement Agent&rsquo;s role in connection therewith in the Placement Agent&rsquo;s marketing materials and on
its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>Payments</U>. All payments made or deemed to be made by the Company to the Placement Agent, its affiliates, stockholders, directors,
officers, employees, members and controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act) (each, a &ldquo;<B>Payee</B>&rdquo;), if any, will be made without withholding or deduction for or on account of any present or
future taxes, duties, assessments or governmental charges of whatever nature (other than taxes on net income or similar taxes) imposed
or levied by or on behalf of the United States or any political subdivision or any taxing authority thereof or therein unless the Company
is or becomes required by law to withhold or deduct such taxes, duties, assessments or other governmental charges. In such event, the
Company will pay such additional amounts as will result, after such withholding or deduction, in the receipt by the Payee of the amounts
that would otherwise have been receivable in respect thereof. For the avoidance of doubt, all sums payable, paid or deemed payable under
this Agreement shall be considered exclusive of value added tax, sales tax or other similar taxes which shall be borne by, paid, collected
and remitted by the Company in accordance with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>The
remainder of this page has been intentionally left blank.</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
confirm that the foregoing correctly sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Curvature
                                            Securities LLC</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Michael Bodner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Bodner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39
    Main Street</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chatham,
    NJ 07928</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Attn:
    Michael Bodner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Email:
    ***@curvaturesecurities.com</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and Agreed to as of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date first written above:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Glucotrack,
    Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Paul V. Goode</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    V. Goode</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
for notice</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glucotrack,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301
Route 17 North, Suite 800</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rutherford,
NJ 07070</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Paul Goode, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
pvgoode@glucotrack.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page to Placement Agency Agreement</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>9
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Glucotrack,
Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rutherford,
NJ., December 30, 2025 - <B>Glucotrack, Inc. (Nasdaq: GCTK)</B> (the &ldquo;Company&rdquo;), a medical technology company focused on
the design, development, and commercialization of novel technologies for people with diabetes, today announced that it has entered into
a securities purchase agreement with a single institutional investor for the purchase and sale of 1,033,591 shares of common stock (or
common stock equivalents in lieu thereof) and warrants to purchase up to 2,067,182 shares of common stock at an effective combined price
of $3.87 per share and common warrant for aggregate gross proceeds of approximately $4.0 million, before deducting placement agent fees
and other offering expenses. The warrants will have an exercise price of $3.87 per share, will not be exercisable until receipt of shareholder
approval and will expire five years from the initial exercise date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the offering is expected to occur on or about December 31, 2025, subject to the satisfaction of customary closing conditions.
The Company expects to use the net proceeds from the offering for working capital and general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Curvature
Securities LLC is acting as the sole placement agent in connection with the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offer and sale of the foregoing securities is being made in reliance on an exemption from the registration requirement under Section
4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and/or Regulation D promulgated thereunder, and
applicable state securities laws, and the securities have not been and will not initially be registered under the Securities Act, or
applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective
registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state
securities laws. Pursuant to the terms of a registration rights agreement entered into with the investor, the Company agreed to file
a registration statement with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) covering the resale of the shares of
common stock issued or underlying pre-funded or common warrants issued to the institutional investor no later than 15 calendar days after
the closing of the offering and to use commercially reasonable efforts to have the registration statement declared effective within 45
days following the closing of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration
or qualification under the securities laws of any such state or other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Glucotrack, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glucotrack,
Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The
Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glucotrack&rsquo;s
Continuous Blood Glucose Monitor (CBGM) is a long-term, implantable system that continually measures blood glucose levels with a sensor
longevity of 3 years, no on-body wearable component and with minimal calibration. The Glucotrack CBGM is an Investigational Device and
is limited by federal (or United States) law to investigational use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please visit <U>http://www.glucotrack.com</U>. Information on the Company&rsquo;s website does not constitute a part
of and is not incorporated by reference into this press release.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements
contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting
the generality of the foregoing, words such as &ldquo;anticipate&rdquo;, &ldquo;believe&rdquo;, &ldquo;expect&rdquo;, &ldquo;plan&rdquo;
and &ldquo;will&rdquo; are intended to identify forward-looking statements, including, without limitation, statements relating to: the
Company&rsquo;s ability to consummate the closing of the offering when intended and the intended use of proceeds, the Company&rsquo;s
ability to satisfy closing conditions for the offering, the filing of a registration statement with the Securities and Exchange Commission
registering the resale of the shares of common stock issued or underlying pre-funded or common warrants issued to the institutional investor
in connection with the offering. Such forward-looking statements are based on the beliefs of management, as well as assumptions made
by, and information currently available to, management. These statements relate only to events as of the date on which the statements
are made, and Glucotrack undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law. All of the forward-looking statements made in this press release are qualified
by these cautionary statements, and there can be no assurance that the actual results anticipated by Glucotrack will be realized or,
even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations. Readers
are cautioned that certain important factors may affect Glucotrack&rsquo;s actual results and could cause such results to differ materially
from any forward-looking statements that may be made in this news release. Factors that may affect Glucotrack&rsquo;s results include,
but are not limited to, the ability of Glucotrack to raise additional capital to finance its operations (whether through public or private
equity offerings, debt financings, strategic collaborations or otherwise); risks relating to the receipt (and timing) of regulatory approvals
(including U.S. Food and Drug Administration approval); risks relating to enrollment of patients in, and the conduct of, clinical trials;
risks relating to Glucotrack&rsquo;s future distribution agreements; risks relating to its ability to hire and retain qualified personnel,
including sales and distribution personnel; and the additional risk factors described in Glucotrack&rsquo;s filings with the U.S. Securities
and Exchange Commission (the &ldquo;SEC&rdquo;), including its Annual Report on Form 10-K for the year ended December 31, 2024 as filed
with the SEC on March 31, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>investors@glucotrack.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>GlucotrackPR@icrinc.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Q 2P# 2(  A$! Q$!_\0
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MS1[S5)/%/C_Q/+J!NYK30K>1]#_H5\$_\$ _V$_"VK1:CXAU/X]_$^RB??\
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M9>+O".H:Q;@#4-1\%>(/".D^)KF30[Y]TUEI_B.VTC6M-E=]-N%OTMHM4O\
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M+4KO^RKY5_M+PYKFF^!/'NB>)?"FIM&%BN+_ ,->(].U/19KRV06>IBS34+
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A^E6Z**_>L%_N6#_[!J?_ +<?SI'XZ_\ U]?_ *;I'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>gctk-20251229.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaN+bP9z5Z8aekhvWB5bfn6nyUmRn5ZFit7FYnG0b8L -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:GCTK="http://glucotrack.com/20251229" elementFormDefault="qualified" targetNamespace="http://glucotrack.com/20251229">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://glucotrack.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="gctk-20251229_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gctk-20251229_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>gctk-20251229_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>gctk-20251229_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="gctk-20251229.xsd#Cover" roleURI="http://glucotrack.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 29,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GLUCOTRACK,
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001506983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0668934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">301
    Rte. 17 North<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Ste. 800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rutherford<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">842-7715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GCTK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>gctk-20251229.xsd</File>
    <File>gctk-20251229_lab.xml</File>
    <File>gctk-20251229_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "GCTK",
   "nsuri": "http://glucotrack.com/20251229",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "gctk-20251229.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gctk-20251229_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gctk-20251229_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://glucotrack.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001493152-25-029791-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-029791-xbrl.zip
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M/-U]1H+\ESG=7X =]=DFY:1AL<CR#(Q[3PJF$]QW5 CKB$4$A$&!VDC!#D_
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M+%?6$&8L_N'FV5.AB3]+9A0A-9)U9Q8B#V$_8!P2!V:$=ZX)S"@C,<%F2HW
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M&F4#F?X(9!C7=UF@TV+I5*83.>*2RL.!+W2*N40\*]1]W,^]D8^/@W7/IRO
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M2M0J0V.ZIB(8?-A2?:!*C*+%P@]:%SF+9#JA@/B>>,=^YAB5O/?37XO3#7<
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MLK<3$#?4GX?!@KI.S)@KSC/JIF'Z1DBA=P)[62[I+YYK>6W._^ED)/V_TP3
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M=+$_\""GC;ELV[W!3^++S<W>E]'L-!XW-JSYQ82#-SJ_@&@K:4\MI#W=)14
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M3B9P/Y"E@<ZB1^=<JP4()^QF'3):,\X#9TA;9Y$;5+&-Z@7_X0N/&197PI&
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MSD+W@VAC!]/@Y!97MV!E^.!:#LAO9]/00T!8O5GLVU@OQ)8.K)@!FS878*_
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MAKI9$F^UFR>.M-#GX"K)(IJ<,^]BJJF?)?NKOB]MT--!8]/.RG.;I'#I36
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M3O)OME-IYM*V[ 3\('%U$X<'%4+7*L4J$=E15@/@*T<YN \NR&P?X]P*.?[
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M7H8 $W08Z#,(8569GM*:E,Y6^+G+[VRWRB_=G+N/ND=(U'2FW;N<5Z*4*\V
M<8G%T<'H)[AZ7!9.\UU+<PS1&80+:1I=1HD-_U>A&<()1,2>##R?/2@%YV;E
MW!J8^'0X-&=??^]\<'CV6_"I-PR.3\Z"W7[_.!CT/QX.S_J#_G[PZ^'9)[2C
M^9/&E YZQ_M!_[_V/O6./_:#O9//GP^'P\.3X^!D4/ZD_N.!^=YOINF]LWYP
M".\X.NP=[_6#\].38V.X'YM']C^?GL%G#P8GG[D1@Q[^YOQXOU]Y>F_O#![[
MZOV;-]W M+]G#/]]T^8M^!RG,/R/N[R[Z8/YG[V]DP%$.(]^ZP:?>[^U6S0$
MYJD'V'O3H^')$?:V?WH6G)X/AN<],P%G)P$TV'QJ[^SPE[[?5NPB^" K6CTH
M/ZOW2^_P" .O=AC:+1B'+GS8C%<O,,\_'IIOPSN@G</SW?\T[S</Z.([O$8,
M^O_G_'#@NT*E1L TPH-Q$' J<+)[IZ='AWO8%.R)723PO:/>K\/M -9.8)>.
M&3@8L].C_O['/CYR[^3XN$\-I4<&NR?'O>#@<+]O/CWXR&\]-[WGOZL5MSLX
M^;D_>+'?[QV9P3.=9]?NZ*1G'W=P>&P:?-@[,F\;GAV>G>.[SC[USH)#6)\R
M^^8MYI&'9]BL7_K#LY.!Y&'->MGOF^=0BP?GIKM$"K5JUMHM;$R ;<&_0H/-
MJC[?^Z0^O;DT'XR^_MTF1W*O.9)WFQS)'UJ[SV@[/ER*)/20<LN:A#X[V9[+
M;W9S CC"<<1]5G**#B/)T(%VBRH-7@#JAMSY2XBL0YV#"-2"O!5@%<#PS=,9
MU1V0G%?),L;7.S!$!4H*T)<U& R1W[B>PK"6/1#1BTBH%$^<G>\^:?U0(F)P
MK*K=$G4,CK*XNNT6C>Z81%U)E:E:IDX?XAP!?PHUX !$A1P_-A:29LZ;)_TR
M+II7Z$[4W[X.[>CR0B$,69(2%MR&&0 -@K^0((=P8U&CNEZ+,)R#?T&5(1N@
MX/'RLT489H'ELAT<$,0/DC98ZAR/HIJOR_#2JRVOIM83KX+4F+3"#_X@7(VS
M6II%G9[OR"_:+<F(A<*B($,=E6=CZ0?,.,!D(SZL95J7,:N=O<K2[P)<UQ;H
MQE6ZALR;92]TLY(/MQR@H*&:9X"/"2TW+P3G$/HI]!(\*4)ML@#4\YSAO+PS
M<%>]??W6^-2 C%E% ,KEP@YF:\FO:PZ!'O-MJ)F'F!KF:!%[QNBY833%1@^+
M=/3E*IU">8:'V>/DVLKAZ-!")0+^YW1+/+][#VEX@:R!2-7-=R.(WA*E *XA
MRL4J&1?YE4OY:^EXCM.4BL3YMU:ZKS'B3!GG=(+:;QV(WTXC>S=6HN2EM]1S
M5G=,^ZXCRYQ@FLYZKWARN0LU=U%YK6_H;R)FQ7=1)@S&Z@?RZ)@-6AHO?:)(
M;!^V5KY $4E0C40I&F$?ME(V0D!,>GC B#^1LY'A[YJ5(KZM'7#JF;/[,KY@
MJ4=LOCI^ZMO5;JF&!5Z[B([XNF/?S=,=>Z%QN?S5B>4)I=8>6GJ*?S?_D2(,
M8SV8XU:C.<RYEIC[=L1/ RX;EU8P2V8R4;<W%V5V?.U01CF$4!" VK)\?P,Y
M CR.PI#NIK<,1C9C2.PW#+%P%HQIVVP.<'A7K-FW&2!4*-(VDE8-<0]U& A:
MQ3-ED(!X'HZXHD2!'-"J=:+E+[>#0^*%8&@+\&7Q/1+:Y1.[I4DD@&3MHI('
MGO=(<+5.<@LK1:YY(-Q^5&N*UZKT8O6"9J4'XQ:/14O0KF,+5^8I)O1T4I?_
M0\@-J^\2$9-'055:Q>OL8(O'53N8.J1.UC7ZXUXF.& :.+MY+*I'U3I>E.CY
M.0?X!WM)9%BKYT'-E7\ N!(*>;P<L'_Z+ C^U%& +I^<!;0PL/FU-]U%)$^:
M0&Z#F52HI[E_D&A_T5T5U6UO*>6[8,,'D(P5OAK(.H;9-":[%NY"T<H] TY.
M5#9;6ID4PDDG"X16F\][G\$"@=CQD@(R+,S ;2H*-CY/B4YH"^HO_.J,4ONM
M=I)_G#0PI97/13A.1L[8\,F#*NNJW9)3@ 29"7U/NZ,K<V&=9P?;%Q/$*K&5
MB^&.Z ,#/D-A)OR".+H":I"([5;U5!9'J,(1NZJS9'M0C\4+QV6%X0186+I'
M2NR'EQLEW'1F'K&71"B(_^ ,=,+4T2!AA(-[2=3,@%1DO%S])48$4LD4ZDSD
MH+9H& 1J6I?<,^LJ:3RJI_5L3#BNU-Y6/AC/G5QOC@'*[D%\[0RHJBHW9;ME
M)\6_?\WG**PARUBQ%-07:LTS+,W ,(R['O:IP!:0 F>9L<_M! R7YHZ=D8!W
MAH &%!SRUP-F];'22V0%58E+XZ:LUFWQ*4:?S]WGB1,,1*E@H9&&.)13U1\+
MW2:P+70]Q![2AS^'V9>H*I<KEA2:VL99)'TFL5'XV5QF!(>*TUS[EC,@^#-'
MP,;W?+ 4R/M-"N1>4R#O-RF030KD;GMT")<%\R&O(+SGL"-I_BG%/C]<3-?U
M/"0";2\^D:"C1&S;(1$Q@B$_C8W]SYP/XW 62NX%&3 PB!PEX;1@@B2LQOSG
M*Q"1Q[!EDT^R=1'F5#4,K?OEU]ZIC@+8NTM?5R7Q-3,H%"9FFZ/66NJH H\)
MEOMJ][S..F6HHM@].A(V,A;H/U^]A/M<W]CM%O@_$!]G9-\_7U<^$TS@%5L[
M92_!AAUJ3-^.&U#]I*;OM%L8L##64SREL=*W>9RKD1!O-=2=1I80GYEG8M82
MFJ'@YG"D1648MI!S>Y&SNH=[08="VKZAU]#+559'R=7,4]6'DF-3,>H"2^W]
M#>:[<]O,2*R<G/+;')WL%@9<@8(E@3/$F&AF-%2YDF0(P._NB*O!9;MVW2OW
M!?*( H6UL1\,S53[G#9%B]"G=O9F_5NI_MM&3;6!VM#,""BW\21I>FOE&1A[
M\=_JX+N:X\)<Y_$<4=#$BXO0P3+SK5W)F,<I;^8NA0Z %GZ&;H5M+XX'B,0J
M@9CJD5H8;VWJ*#:, 6ZN<A7L(#<$KD[')Y>K565:]B*=O)@#U4$AZ;L<0\&F
MP1W%1U(_O+GC]QC?Y7NW?+=[=[%\ 9?,:<9T8(ZS1X*!\RP=+XCU!J@9<+S<
MS#:>\A6^?A )M*&L53XZNFE->V^VF!;Q?!J3IPGT!IC+2&\@*SEBMCU<QC1E
M#3<+-$B?K*MHG,VR]3RG2M"E?/J4XBX3R>]*6*WY9JQZ5!W%LUQI"$53I"48
M9@N7*G-9 ]\U-]FF;.;1]P@%RWQ>/H H7),,M+7!?D_CI!!R)U@8S*=M,=]=
M"7O:3]AH=,W!BW@"%*+%^(DRMW2>3$D,>+F$VX/%'JM,LBSER27_;M>S?F 7
M:5<@D?$UFLT=\(+46RRY6NQA%]!(A(B]#_NI3TGBA;&T/*/XO?J,!.!=0KSD
M/(U@%W$K)):$.*6*V$XU5U1GC.)]-](1.C\JHXWA/*B&^]2>!PMP#K&V$=ZI
MBWEC23?WE#\1YS[C_N;0>-0]>KO]&FLE#Q99$N=73'&FQ*!^,'L=LTL5@:AS
M]!Q<@B.W85A"T2$U6=@!7)6R.&^2W-MN8$!?=%P2QRPBR;)199(Q1V*DX=$G
M$:0=$V) 2RU#7/5XJ;O(Z9:3E?[J-;S=W*KFA\N.3=7WOYKV)L9@8O";8 *G
MX)F9HP=<&=8?0AJ[7 K6;6"5"^D8/T0' 3=1'6&763@2ZZ'#_@9*6P'!FC-[
MS-D"#[&!<IN?LBZ'UD8N0YYT9[J!N1"2LN/&^3U.G&DR1!0K!PO=+(RZP[KT
M[*]0VR?8(GA34;7I+!T"&"^]CJN\= Y/#C*7^ YF!?-<HK(.'U<'*FF0K:KH
MIF-:[HA6#Z>0C?5K21::-3OT0=INS5*LG30G^B2>%$N8P1$"679>_EM'OGJ=
M%L+"D*5ES"'K<X&LUR5!0\W<$9E8>>U:SR5@25%\.U[;QBD!AC<NG*JR3;N)
M-?.:79-71*1P1/6UU]$>''EE7'D)T1RP&QP8-23**;]E74 . &@ C= 2U84K
M;^3)%2FQV+M-$'N9)I<(0_2X.-=??9N+YJ&2!&]>;I($]YDD>/-RDR38) GN
MVNY[P_SN1729*:M.PQ$<,A0<O"[)5#JH(?R7I%_I+Z0VO5AZ(<L@B2[-/8@Q
M96<>,8VN@#;;K1(T6<RSU_5.(9-]$LP? 5+4"TDBHUN+C;5MK3QF4J%@!6,'
M-4<KC+(3+_;#B72ZVU@)E9HBY &Y0UV[F@-/Y$JB3G)',L6$NRD!684@M-IG
M 6?W!1-=T9ZN?2K<Y'A:%/K1FYOR4??H[?9;HKAW:_4(&&7WK=:7^&16=Z^Z
M:<'Q8F?!?0_?W+486$27@(4=0>B0I<2L,/P?$7F[6':M1S<AQ/<>8Q1)LA?"
MJ ? \/'NQ<\ZLF,S<169X#"WRL!H8H(8<-<+38DPB_*PT $MXW ]8]$;,N=-
M-@BMFAW>%2U,H8.IJ!""E\'" 1@0$@*5DK@;H"L1R26P71&%0TD" BK7JJ]B
M@Y1R1=<2S#D?Q=;<7$3&(P=18OT%.ZE*I%2_HAOPF<-'%8UVN0.*-00>CJ(=
M%D&-N9=Y84\@3W98!G=<$UI,@R]1-*]^20O?^;.F-4=85AGDA'"95#03=4W5
M=,DS!@VPE'IV%3CT$Z[,$B-=HX>(K$*2=^]Z-0@2.].ZK%3.I7>@'^%87;O(
MDLU,YN<K SHV/<7B8H&Z@FJE\*5QW<A-]C4CNV:@BILH2GQ'3PD7P<T2C^.0
M_'2K:60^'F=Z;=>I)K9;M.*5,B(\0FDA\7B!NWN%I8>8SZCLHWHA)?DR=HR^
M3I,/!UD,C.*XCE29:/7ACB<10@RX6O$3]%"S#& J)21-O_3F,J^%V34>GE0M
M(Z>G%N1U#G)6WT9)LR]K5A1^RUEB%E5*GZ3M[]#\G!LE1YY. -[?58^_U#G,
MXWIO+@,RNZ3'Y5#OM2]P'V>4^SKO\$64DW!&@1W];OJ3O,R9M4KM&Z'Z\$[4
M3R"FSW 9C;N4]YT7%A/O-#?+S#<D62%Q&$S(86S.W:Q4+<F@&BDFL4Q;=M72
MQW $:)RH,!1SX?63EY)&V2*!>#W8>+?QAQ85DP$&A)X+>@_49FH4C&G=%"$]
M&;&#ZH^5UBD7E'$59=W-;;E=T>0&5*YCYO>-[FYU#9F5PH=7XV*2N"081:$_
M9?44<4V24K82%.NPI]ID:;><S5+71QOH]L1/;E]0U3'P:>\KR\V=:W:9U9DA
ME<7E<L.N.7,X,1$MI7+#HREB>$QG'I;!?>-'W.9'[* ?\=^#"&23HO'_;(.W
M\)=V\8G/T)KQSU>;^.>]QC]?;>*?SWJ;W?M!^-WJ'#>>BPT1@?M)_+9;C9G?
MX"],_"+>M2'S^PVIMV]/_'X@6\S/_*)!64G]!G]UYK<B..IA:.XD\WNQ1N;7
MV7'UJ=_@3V9^1VMF?LD?7)7Z#>XF\XL:88V+T (B-@G@I]FC7D'T.1B;706=
M=:AMJJ.6U(W*@_0D#[(O5-^XSN.OP=9W';-'$@R?)@ )S,/,PFG564F43P21
M#2P;M,4MU3-PZ8+^/U'!3QL:2O+;K5=OWYJ=".7@%HZ-L1IYO"K6A0VJ=,/J
M:$BZ96 /%&*0&PBU&=@X%RA&%#66"BP9O7$KGT"9X8B:3[PA,6G4 N#4=)EP
M]!B=@EA*/LKB"T4X!E^,H=]8$0]?,..#N$3[)4_^0PG6>=XM=LOU(^![AJN?
M/(2C?N_KCJ]!6\6XM5L'YM'FS1[ ':X-]+G_P@(KQ&I6JZN"U<55%W:6)=?*
MN.]P28(LYL_CA2T1@8N2Y.6Q(0CH]5<_*LI+802WS15(P/6$*SB)7F *Q-Z+
MK[9WW,4X-!>,60D$QNW-I':[8035UK,@]B5>SV$-*C'@">-VX$)$-FJ@BS-+
M8.O-RQ^'YZ<_%5<__@O^VX&G!5OF) DH=8P983R-N)0#S@;,AS"50PQ1.?.E
MG(FQT J#R+H/A"2FA[#CSASN7V.+8Q2 CL8V2E0ZCG3,3^]*O.3Y_E2(03F#
M%(\W7*=2Z883T4@'57^N<!1IW VNTAL862[#,0O!M( ,/LAZL;5P>9E%EW@V
MVSFN6;GS,*Y8MJ5",# LP0:\B:;7D5I4KVE--2T<M<S:+5IGE#SB6@<<$#8>
MZY)$:"B!W>V;U!Y$^CO64&4] /,!%EDR&W&MD\6XN-083.(*-\"*92*?=^W$
M$4QK:4;H LT+7.6\_8PO'P'= %V1[19?PS00MRU2^W;H=IS@93'VB4M0>-EL
M--QGV5CVV>XBCQ/81WX](JT:B.!.^!679*9F<6XYY]=ID&P?3,%I!Z2F-!&3
M(,T/;;?<4Q.F1IH",4>28#G%NF,D,Q1FCN%38/Q<B ,'(]9]DKT"!Y$]A]HM
M.?#QCWF'ZS1QODW#)HOI%$/\Z,UZXEYH(C1M#*O2ANL:^#,*.,!E0[J#HW'1
M=KGBM2DEC#TLOP6]6[K]U(4(=%PX*ASF!I_:G!%(BFK9'JN*J7 1F8MLQ.0]
MX'9#N0,,)3:7=)=1K2U.?E\D0F%E-L=DXR,\ZAZ]W?X>(S7GE-T[!7GV:)PW
M@5R$W"<Q9MZ</^N\AP;<EZ.B@=5^&268_QFEV1RWG\6$00J2SD7*LZI$5R-!
M*/D-*JK ,1US<(RNC+DUA<[#(LV[+G>G*S''-H?D&+96A(%6\?761&D<WD9?
M:[84X@W8+% *L;,U[D@@2WV+[G;7Q&86R-<OS0V$0;6T*DV-([:@\0&S\R;-
MOA#MVCR&^MD$IM$8L LO4YM'DN"F>?X F,&./;',2$F-%]N[?O5FYO^[;P;W
M&BY#JA)#F\MTXCI.IS:"<;!WVH._G1ST]G3.;7.&/!C0_/4FT7*OB9;7FT3+
M!FA^UU?Z.P::FP,ZH;I45=YD;4BZXX=^]-<R83NA,^^>>5<5MT/H9<PO(VP7
M! T1_F",>T48,<;;Q\'2%%8-^168-;O+2O?F![#)$_S) =<(FH?WX1;^; %A
ME)'(A=9L@I9HFD!HO=V*[ 449*GP9W . UYLN071#\58OH?F"0,\M6R@'3[E
M"QKCKSI=QGW0DV^N4DE*Y)41V5*9*B"H8Y/&F@<[#6R>T&N+UW]9%YGON.C=
M[</MT(&5<8<.NI%??[B#/SG:X'"L-]SV$SS*:!?.N65;,.)F*+SH@(S^*4"^
MO%BC&9091I^(BT9D"M#'2W,DZ)C&%+/#J*)">W8!I!.#E0GM,&V R#I\AAT]
M^'W.AJ>B^W"%]N8=OR_&EUQ&3T&<7+Q/)(IDLD)\U"(KU .=AH#Q[<Q4)]$R
M9P<TF,B6H8]#X!'5*;CA#MU:<C!Q=##^GB^XK@,U 199.2.(@4VPU(A;2=*,
M%OD,UQ, .2=:?ZZD*MY5DN)=E0N&"1<[%K(!8^#4(:O8IMWJA,MCC4BMA[FS
M#>I$MJV^!\18+D/X5QG"=4I"& RP:[>, 1U"34#7!^3.F,75!^:ZK"C&BG',
M58:E@JU,):-8UBLM\[#@5-5#1&^M(= \H)4AVI*"&)3]&$D U!AM$*$A?C"$
M6H>J>,%-=]V*:A*FUPN H)6R!)S'U3B/'L0ZQY7J,2+DS8L;(R@6_$\E/'I2
MZ.'62\EKB&1.18^#9'#-5QCB"+O6D\&5QT&Z!+AZFIY%7C 08\5TF@IG,\!$
M(P)54_Q3Z<I/LG Q[@:7F3FIH 3,'$UH2B)>TUS1D\4TF,4YOYOXM"&3U "\
MK*??6'7QU^P5IP,+X3-SZ@"TMV#&5<=$J\KS$=#+QZ_;AAI]+R>QG+?V@/6.
M9CKMMFX+:]UV<G9*!S8RM5(<UOR#J:'AJ37G8$R'BSG'LX6(#$67B.S$W]AP
M!.=7[($)/&*B#$$)/%:*J:.$[S),VQ*S\!I#55] J'A_860PJI?(6>F45&RY
MC_KH',)X .+/]%OHP%O9?SQ^--Z8>^]^5^UT.02#O1Q38(12:&:=FA,I),%A
MC"QCX,E%=N2S6WP%C!BW7ATEI2!32)43?VF*X51!8HSBS!PV)(TLYY&%?YAM
M ( ,N)HZQ"0=Y],HI#7'(!T/@4QQ%E36+OW>)9[**R1'H$[JB,3,&^GXY;,8
M3V$_>WP99L[**I\P$P)FT>I2DL=Z>S><3K"%L2I@BHM,0H)$I2-I:>_0U+/O
M?ED*K#50$94-6UG>.#3E ]9>PU!42NM18DC41)J[1F6HPXDV!VS*YR)+%[ >
M]&E4&12_U)9/<#H;^:I!' ,^J)+B4K&ZVNDJE2\ ?'SB#Y^;QBX9K=6,=S59
M@/H+7#$13>"(LV ZO >4"A<X;NF-&;BKE.HJ&O7%_6N K9/MH%<=M,9VD<<1
MY!3SC6P[^$C2Y@BQJ65"12@;N-0=,R87C!RQ]K <ZLJ!8&%UF7?.'O$'FRR:
MVDU.>WGK*R7IJ#_JA#6/ N &8C8DFT( L(6YI#+CS%<"SVJ"D>!/_PV>!>DV
M,%PQUQ=JEX#A/K#!6&N/YMWL'@(HT% QYPZ/O9WZ#-G[Y X*U9XQ!HH],-7K
ME)8;/Z2KSWDHGC.7?2'T?LYPI+HJ70:'E/$US"RROO7?ZZ:FKC3(WQ-8G9B;
MPS,731\Z\E5_:A=,DBI8(B Q6!')7[!^!@7-)5;( UN%MDO-82)2+"6W!B!+
M B=2W/4E.0E>DU@+&?F@J1JZ^M05(G(MCY1NV42 V3J17[954[-% ,?7G?6N
M.G8ZT91C0T[L.()<"2X&5'$*XFXC#&_]@-D>W;FKV7 #_D&?D]9#7(K+K59R
MQX";6ZW2+MK4\0C2UDL/H,GX#SEG%.X/P@:NB,\/ ^!43DB\,*3UCO)$9B*F
M.<,N@..5Y",U'N$'AU1IMTI0%;@WT&.TK B^!X-K%YV<+A9(&T<@"BE5+<$0
M,A,IXH%'RFP>X1KZW70L'\<C%\4HWSQ 90K[S4)+4*D0>\&9+1ZZ;GVAI[UO
MMV 9:]R-DINQM-$:<F'\!F-/&AL+WZ/FR#>QO/50>#ZL,_\]J $!&S44#OU)
M+ ^#@7)\7ER0G+$E2_&*\C$A%HUGB'$!*P=:S6^48^5]4HP:%T'6AHVQQS9Y
MNP?+V[W9Y.WN-6_W9I.WV^3M[CIO]Q[S=E0\:G-V&D5!*;N>O>L5O+Y;\0@R
M+D)MP'%3GF(1T:V('\5/ BF(<2$M9HRQ^04U7@3<YG!3S0GGA1JV8.1#IL X
M8G!#WDI,+S 2!O]@%3N8EV*LV'HI*R%9@Y8M&6'2T17X6NA_68VS1(*ZJ;%^
MW+ODU4O<)D=Q7G#"M+I%M-]%1!^6S27%B!46OV0<4U?>GG&<L"2P3'([E;=E
M@7$U"D9H^@O($T0I,0BDXHB20<QU'],E/CABOA6S)=T?'*4!,5G4%3% X)RV
M"*E04^,BKYBF$7:>LD]?:BG+0)+E2YKC_@A,ZA_?;JWU?']N)J3%SI-3*:;!
MQ !-FHT2^2H<YMDD4F/SPB@TZ!%8L%(D?#NQJ$(;T:#< P63UA@VFBEZ'H2?
M%9><A*0 'MUN>9%JLM#7FA:*?-.RL#,ZMJ-IW4MOSG(EE)M#7 3C&26M0S<(
MV')<0%(I:)U[O]GVCE + $]9?C]'!BNZ#:4&4D@2WX]%61C.8JT7")E6F>]U
MGI#*$;L"^E0J&B[_KM*$%TO)M1&W((\XMZC=JEN'?^YP($UH"EG4'0FH$C0U
M_<S2)!XI^<?B"D/+^(U&A40,^7 !:@YQ$ K<CZ91F%'-*P%ID01K=<(+0PR$
MKQ<)"DAR3+COMS5#+<#;6E*75L2OUXS#QDU\U#TR-^ZK!Z<U>?:S=N<.DIDV
M$AH8.DK2/A5[#$-S+M;IRVS,W4?6H:VPTVX=2'V%9IY@%;GXJYG/K>]>8FFE
MEJNS<MD<DP0MYVXCT1W\=R@$@Y;15#3EN@'&32#NS2Z4C50&UCW#IY!X.,67
M+?4B,/6EX.2-/3Y&-F/KG,-5Q0.8"L<D,_&=$HU9#3("6U0/=' )?X820B2W
M27*F0O*A/]9N#=#]]5,!8JDTMHPY68<OWM5=E.BD,NK2&(-)-#$F+*C9W-=-
M:5;MTV:Y6=&!=:*E;S?1TGN-EK[=1$N?S59[D&OP8O4UR,7J6Z]>,Q?);3=A
M+1+ W%)(>QVQK)>C)$XSN@'1?^1+T+\#6;R=>(#XCBLCG#SZW*%'Y[O^_8=\
M6&&[97S4"Z#6Y2CQ(HD%_)9. *]QG4ZOZ0[ZQ;P#W=<!C)M*3&\K6'SCAQ1
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M,N_$WW>-:_2ICS\?]H=!O[?W*?CY^.17\^PC^/J^><-9_QB>VSLZ^LWT[22
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M^#/]@,<A;$8J!FTW@ ETLQ&=EH5'X )Z$'-IK!8E]$K-YF1C1PGLHBD]B^'
M\#I*RSR>>ZD8N&1Y.&WPE8.N ]!7*$"=>*&*_8!%:_4R-Y'C!&W=B&SD<H9I
M1B58+4^?/#["IJ=E?!D4.N!+4'H5\5V0B'$TPL@]]"2 =XPYHIN7LUE,[^3F
M<(Q6Y\VOFYTI#/GDH#(>RPDL**-$J"$X<-@G"3HW&V#>*+VF]"=\>\NJL3\%
M#S8%9WD [-# 7YA>YH1T($2L'H3O&6S#+,V+1V;V33OF#5-TTJ * =^29"KN
M7!;"Z,A%#?,V1GU!1?5;G^SW(H':FNYT F>K!8ZU20DR([NTP;G(V4NXS]G[
M-8%-@><A2D24P.W">U92ZQ!)2=]AH*9WSBC,K.TWY'V,V=CA+1T^>EO2R?TS
MR+( M_N>Z?DYM>)D&:KTO*K*VP08A_X.N;_2N,<-,C@!I$N))C?Y->'?=(A)
M,H6?PVR$: D9INE: ,]-21PD%N+">0:A[*H!DML$V@$1B_Z<*RV@04H&V5CY
M.=47^CTCN*F;")%?>]#C015CU;(</ 6>,P/0XU&:)*Q/]'LD(CFGJ8@>C:.8
MU!./8",Y]5)P/&:2U! OHVN<*I9-:J3V^.RI=K09NSW"D/5[>R$/*C=25GJ?
M9F8]S1K2LS3(?!9'F)\7(<XEH>=9Y(XM?<N'!1FI% 86U;B+H;-QD E&"<?5
M[U6N"PS37:8P3@?WY'MUO!/UR,8&52X-5O-&(:XF"^&6!_=H0FPX$']5HYL,
M/FL:1$D1**25@\3A@^[C,,E?'20IPW]:M R#4;-O3>H'IM .:(OG#*5"04*B
MHJVQIHLW#V(Z<8OF" S;<3B")8'AF3MO.-?3H70&[FE=6Y#+M?T-I&8/,5<3
MM@?<K;C!)@J&QHY<4L9&<#^RPY_&0DWJ'K49^"R05GN]I8GE2 /0\%+2H Z>
M/J5%Q-@&M6Q." +-1ND45AYNF8CC.XAHHYE6I_0ZC<LIH^D"./;9HW3RB!Z
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M@2L+*YD$L.2W#?$_^2HA_HWG175$8;M %':X"T1AKL'KK?&'J4X[=K&M5SA
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M+<>H,F;J8TVUDW)QT+TD+!3Z3KMF9T%42VIJR5@ESS%FWAAIY?!K/-.WC^D
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MX!W/?_R>D$IIIJ]3 M*E9:%)?%M4E#UT/@CS ]=>PMHU"II"Q'F1)A#(%['
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M6@EP*_M1.PMSNW?77\(=4DY+X;MP,?+,',&?N%[!B!.01N:;JDJ)#F]HJ+P
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M=;][TU>ZZG93!-Z^GZ16;T3>;7)9/@1ES!WY/_O>KVDZ#AN[^-"7IXG,%YW
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MYM/V/5_T1_PB/BV:%CL4FK]0SE*R![-1E&LUZ(; 3058LV]1VQ.EER).QL'
MOA 5-*#7P24A:A_V(+^"8=#// N@8=(TD$-%WH!TQSJD\$$XA#_ 3:SU\'/=
MRC'/Y;ENY$]I1,(/4E$<=5&</V4CZ["&:JBR*A':NZ3)I8(H;5\7C%+B\MD-
MHB$B\80:F_,^6E((C%+62GJ30#M7T8SZX73+-6^4(6 FJK53I"ES2(!C';!
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M.S[9IPG!D;,[V4NN%\OR+]_*R:L7;S\O]4R7X]&3@[W#D_U7+^YX8P]=2'^
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MFM+D7<<X!9O>J$1>T821R3.3RU)C^<'),YFN^]/N:-"/"7*9E@4))JOR".*
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MFE"']F;3N9-?89',TK*34EQ DF+I4!SWSJ:>960:.N6IFXZ>^JS=Y&PY,N+
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M._A_\3K8/OUKH/:?!Z5_1?3_ %!+ P04    " "O@)];ZJ%WBF(O  !=(P$
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M<"R1=. ,(%ALG59.9;#^BDB#+IG/S BCP.8@X:Q&2:(V=(-@N#TFBX"*1E[
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M/%KPI#4&4JG]HQ*84ZFIBL)82NNX?,M4,@W;S^ PP[HTU%8<"3*W^2,ML.+
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M[L%O/\^II,7+Z(,JJTW2U[U+/[HM;GW\YO/;?Z!R_OAO9Q\_O/X_4$L#!!0
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MW:/#PWU>)%,3[!P=;@=O#O;VX=,GOPO!'PYI$X_P'@3OCF #Z9GPC!W@L0_
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MKAAN#I6NI<F_Y@FCKD?A%*@N-4@\QK-!Y&=A6EVS+*.+^1^/AUM;6PTZ7A9
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M,T#/N@Q0=U&_>;BL(5Z&W];)DH9HV8%7+FX!+[N.F $NJ?D"0]6SC?!D7*R
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M("*E.'*E';BRT%[951>7;H$<53V[>@=_V_SMM[]HA+&FHU2WJ(D!G;F -YR
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MJ;[U2YE%_=Y*=E%]>V\RB\QA2GU!C<:Z,=32_MS01G$;8\AY]S*F$!ND"ZL
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MDC6SW3LQVP2-3BKS$-!3#8?42?%"TQ3:17=^/,A!1O %)'S9I*D<**EHL)&
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MOT_?#0Y_'1 U!R?'QP->)%/C[9\<][TW1X<#^/39KT+PAV/:Q!.\!]Z[$]A
M>B8\8Q]X[ ,PO"%G]]M)M3N7!ILCZD916D;Y+4LZE!\H6<XO3@[^CE<&I,XY
M\&G_#"[#Q?9<O]=S_?7=AX,3D%4'?_>[G:/C@XVYHK>_VN:3O"#Q>#!X]^[\
MM'\ &NAO/^W]1/\^[1\>JG_?>/W7<5A>XD?W_OS2&V9Y&.4/1EF2!+,""%(_
M_43F^ZN+LR^QS]GL/_QBVI[M_?F6F>ECD.=!6C)IYY=!'A4OD)^\Q_[>\[_Z
MCWY^[.GMOSB\G26X7$-&_A^SPH^*8AZDHXBI.PS*B-=P&(VBZ3#*O2>/?._Q
MWN-G]E+@/V=\E@^)H5YO!>!M+ Y_T[ \^66<AA&]/$YO<\%H&'4[K/"\9GWG
M[927D3)L7WU0C/_JX8?7RK % 98#K3&\NKP,2A_>DWM703*/O!PX*;Z*0M_C
MO=V<_V9YMQ.7A1<4!>QW45WFVRP!.>:L,BX\.(.X3' Y\UF6>O@5D-Q3>$H:
M>L5\^'LT*KTRHS\D\30N@S+.X.'PV>ASE(_B(J*/XM]'61K&].=NYS+*HS@-
MQO PKXA*W,#RTO>"$CZ]\$HX1'P$["I_!+]^7F:C3Y=$I=>?S?(,-IRN<'4E
M1RF\!?XV4 3@AYR%(459VNW \V=Y#/^%%3Q[L;?GS7:GN]X.LM,_L_R3=Q"7
M3$S/D\6/X6R]110 86D*/^=%D"^\;$Q_;'QQE;H+V#Y8.>Y#C;!N9S@OO30K
M\7%Y1&OWD3C8Z6*4Q\.(. W)G\WST64 [QCGV=1S+@C=GQ)XMH /P]V;SV9
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M9"-)LC+;X'MPVXSQ(U^$Q_HB*!%)O_AQ-N.V#U^6@F2V+&>MC7'6O'?;BP[
M<K&.'!6K937O>O8?;$'!+ET!1O,,%#P&!4)ON' U\#18H/Z=!B'H61!YUV "
M1F@9PL^S("\=HY%,NI*HKYJ/S<896X+XR6$$4I5E;=5$0YK"*$%S;Z&,727[
M8$6!%\Z3!=J[HSFN8!R,"C"%$[*A9@M\^.GA&X]^!A,(C&199_1@&L2)MP,?
MD!^#L@Q&ERB,M8ESG)5BN&C*8[%%P;I#,Q1>S%H#[:H"+3 Z"\HW>7T\ ;3
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M%H,40N"(6,Y7.O,()#/*J6?W@N=89Y0*DC^V>&"41N41M4A!B/U%76=[-,N
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M%C_9P]K@:4EVW>,B MWUK?%'\VB2V=ERG]EE51U$C<8:K@#5:97.EN"O&C9
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M#,,<$W34[FPJ;<&O\30HE5);9]$$1P+4*\OA7=CG57J/]]"[@LL,7Z?J1J<
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M(<@SG/)7E@D7HX(Q=! 4EPT.:IA%7 $C"6H[4B,>F""52B&<J;RQ!O;EFJ;
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M)&IH<!IYEX2<J6Y2,UZ/'EO/42'\RB8QY%:#W.)RIZ)!HJL*D.Y'9#8,F,_
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MVK>\-7>_CH?[)X?_1!GW\.W%^W>O_S]02P,$%     @ KX"?6Q!QKY!+2@
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MO@$B_CU#2QYH]9X\D2S!M_N'?ZB)7$?>2_QL 'PBS/1GNS%<%6\;YIZG<13
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MJN##(]/'#\;I50BL@7]7H%DDTR]UR4NU)F=ESYNS#+Y,TY0%UB],WTV(O,+
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MRS!7&P<<0*H2V'=:@\!6SLP6,-^J_'86EL[+#5:VAN]]Y\*"HO(=*UN"RK1
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MJKCQ@(W[ROSBB]SMJ%LJN3AT$Q9Q]<()99PH8@R"<Q7T4-=^1\P+;8;@#[E
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M'#2ZKD=I'*=7.B#40.?F\MGS?1?ZE^(>BV;O:MUHR"C>>8!>T+F-!83K@F!
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M1H'(INL$+_>V1\V/!JSVA['%7;G/?21:(P:2,NDDUNU03,;007(FD6B#VV_
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MG%Y%UG7?H_P8YFG,(Q;=T"PD1W 2:-58R6=G!G,MO<L@ ;67WJC+XG6F5:_
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MW@=AG%[=CP1=+B.$&.Y/=IJ(!=_FG/_?XG\/:/O79:?OW@& H($ECF#!I)6
M)$:4#$J-4[[L['D[(!H1O?B(1-9#NO[KLO_M3?_1B]'N]X/9[_9FMSN]!CM]
M]T;PV>'O1SOGGT\Y)O/A^./^P>G_KNEDUWHG,81-4 >'R67([2,/$%,%7G7-
MO5WZWYJNW-O#=U;E$JR@W9.-_I R:DUY9;&NZ0:KNZ;+J ]@W?+=RB%<TX6C
M%*V[7;EU73J$3'W=[=S&"CW455N_C)IE^J"\://;[C2_[46;WW8/MW'%'-"U
MF>'!/SX<[AZ>=SN[#V66:VU=W'[FWLX9VHF?#HY@#]\?GWY:SUD^G!VL]^C\
MMOG\Q2V71!Z^VSAGR$D85\6GN6&A0?N2*F2.0U,F#"&US*8($Z]AI:.$<"@Q
M/+SI[:?<:B*WO^7&M$.[UEFED'4[W$QZ\X&#1MS^5OQ\AP\82;?SQ\['SP?>
MZ<'>P>$?!_O]^B-(YPT#2P)!:2 G"X6GFH4:6C67\'.1_DRKV1;$+T/P7VL*
M>S=?-3C4'VI5GTSFV:N&R3S84C<A_.G#H/OV*G=5V?BS>YG8PZZ\?- 'LB7V
M1Q)[YTQV@S/6F.R3+$J*7GM1VK/7$OO(Y,6=,XJ=(  C,[^KNOCVP/THS:N]
M/?=P>];M./Y$Q+8JV%IM9TOLXR3VY[H&)^,T$8Y03O=_;!OWN(EM]:['<F76
M[>2UQ+;7X ;S/YCXD6 .MB9[*SK:._,3GKR6V,=P#6X3]WW[AW@J,'<\>,TS
M*.5]P^]]KY0"_MAV^U$1VW+HEMB6V$=P#>Z<*W/'V;]D^;]GZ9N<J=?5>:^]
MM=51']4Y?53$/OQ+U6Y62VQ[#>Y'MBBW4BM96F)O?J7NMS/%#RMF6U2Q^_*-
M=SS%XA^X2Q_]O&C+=N^@;/?E3<MV[[F(UB[NI6%_W3W>_R?>EU\_G'_Z^.[_
M U!+ P04    " "O@)];F<AU/2T-  "X.P  "@   &5X.3DM,2YH=&WM6UES
MVT82?F<5_\.L:M<E59&4Y"O1855TV=%&<K22O%MYVAH 0W(L $// **87[]?
M]PQ D-215&QYF3@/L0E@>OKX^ICN\>Z/5V>G>^W6[H_'^T?X4]!_NU<G5Z?'
M>[OK_D^\70^O=P]^/OI%7%[]<GK\9J5O\F);;&Z,"G&E,^7$>S46%R:3><<_
MZ(A+975_!0NQ]/SWKML1A;HMNC+5@WQ;Q"HOE-T1F;0#G7<+,]H6(%$_B$Q1
MF(R?K>P]RR,WVME=/_\L6UL]&!:_<>?=@[WCVZ&.="&VMGJ;N^L'>Y^+C:^H
M@53U?[,"3L[>B<N+PS<KZG9KJ[OYWXV-S=['T6!%[)]>O5E9^3KJV'W[\_NK
MYG[=OLQT.ME^;$?^UNE?E6=PJE@B^(=D\6P&GA<%^YP\ Y3OTC(VA97Q=:?=
M.LGCGMC/<U/F,0B=6QWK?"!,7_S]96]#G.DTU2:GYS>R4.(\E;'*P!5_J1*Q
M7W2+H>J>27NM"O$A3Y05[Z5+Y"=Q4::@.-;%4$AQ":JI$B>Y*W11%J I4_RZ
M4:XPUKO&EU/CQQ*[]B?+9?LOP/1%"5O9OK$)+/_^G[V..%(P9P2;O=CHB.<;
MSU^)KIB%B&"$K'J;;HMWAU<_K9&]Q"IHB6=I\JDT.X<F&\E\\LSRK[4.#)ZI
M1,>P<:'B86Y2,YB(V'\%ON+2 3LF;[>(2*(<).[@SQN5FA'!"Q3RA!9DRL8:
M&OE5$F8(E[G!5U.R&AJ 1&*DS @ 8[@E6D:J($T4)I$3T/+X3D0QE(5 0!Y*
M)]BW\$SGA6FWI' J+JTNB."HM#$^44(.K/)X#SAV'L=Z!L<ZX)@9(8FFZR&%
MDU@ QC<[&R]>=%YM;0HWE!:[X!E)"+&P.+X6J\:V6S-/U*<2?I=B?X=-1*I5
M2?2M,OTUICV6UDIZ6YCIIN6(?C[O;+S^KK/Y_?/[MH,F9"Y4OZ_B0M\H>AGI
M' H9D6NW6Q0#7O2^_PZJM9Y&;130"#NSR'( -0TH/@RL<5"?-;%2"6\I1_AU
MJS.\32<^J&0^J'1$I+":[)^48 %A9U2'%SF@__>5<C -=C4D-NCU 6U\J&Y'
M*G?*]<05U%UK80S*L.V-8LEN"3O0!\LC%L7I^.]S4X"3ZG,9P5IE7NA46#B'
MA@=C)7\_-"G"&_@AD6 6;P$B 78T!.F3&B=*6D#2FHRAH'- 2J93;A)HHK=D
M@6,IHQV0 7=*C0L)C:Q1 T@[QE!<4% PPL3P?4$!!FB.3%DT(N.FCXP=X<KH
M(U;0]T3+(22YOHRKP(2@ABI#6@2ZL&EL\D33:]=KMPBH(4Z&K=EK$0F96H[T
M6?M-C9Z:7W*SL;'73%:.=!'@!S=1%G^/C1T92RZ(,# RY!I+9JZEQ-AA:5$7
ME19(NYRFC]/30P*8]$$-J8;A8A!8Y@,<@CI DBL/(LXQ3;-_L^%3Q0G6^$RZ
M)CM0>AH8,F*C.(!E(T7/,IE0?$>>2+7,*<7D(>]D([9G[<:@HAWJ*7YJ*:M;
MCX*2"^9+;_]VZ^6J7%M]OE9MWX#4?LQY:',+)00A2F(Y\N9,%3;[>:,8RY-U
MA(\+-2A3S\(1A9JL3"EG)[ZB8$[X6TYP*8HWRH2NH)C2D#Z58^>K,P;U] 6G
M79]+53Y-C?0DY$#D_ZC2!5=>7OI%23O"V,>YP+DE1MA+J"*;=.;9R5#WA<S.
MMJ5ZTY(34L'''W\ 5WAZ2;0I&\0*N$3T="75-0C-S>JHW9JQ(3/$%J2$D8L&
MK[_#_.X>0S,,RW@HYE70;BWHX+S!,)&"9C-?>,UM2YT+URAHF^7O-/)4I:S7
M9Y6O>!4GRKY.%17+]VBCIO.A=]EKBD4B'=^B/LT'3#;3SM'2&?P>'U:@152\
M\8G/ZZ_IE'4Y.U<L@V+IK<RX2B=<45K5[9?L*G@Q6[NZ:DE0W3U%?6Z@ZH*!
M"DMOOD+^146>2(M2;@+)^@45A43@OF*#O<6G^NF1!MY@E738BU'31ZSQ%0$[
MT@)LICI.5)Q*LMRT=">U ]4O7[5;S%/?I*D95^J[AZUOR>5)DHO&"08HQ+$(
M>4+1^0P #H$1N=]#C@\L/@<! 4[A/046BE<Z1K%7U9C-KZ)R0O9TS;#7 5D;
M-N"P3O&//)@<B(]T\RLH&O(''&*QV)^T/N*UPPF>-\8GXZ%&/.*@Q QTYEBS
M/F^.38D &]$)"N&I7Z9T^#*V\K FHL&-%9]*J+Z/$,=4IOE@+LQYT2=^_P<X
M_7R0?K")^*6;='<B?8GE63*?W3W8VZ<S8+LUWP=[LD;E'^_9/Z7"%CO*J^_W
M+X_V_Q7ZA50R3YM^XHOV_+@CU&Y5E0MV1B2Q((]\&S;CE"Q2DP^Z5"T)G>%8
MEA><AQ&1<6@K38DB/S4&!VR2#1$3=8-&-<!G@0GJUZS)0:IOZ,4L(U\S%LWB
MY^E#Q](!]YEU5'@Z0DZ-@ -&P+N @#./ +%Z>/#NC#'= %%G!D4!(=QM#HCB
M@B]#_B^I>)W%5DJXK$<E3N6.SC]$6]WH8D(>\,+W%2F_PX5@@60BQG@20)N-
M3,Y=!3YV@4R&,U=&?2$H+_()U_=*IR(+DH/%R,,D1@]D*'Z/L'&L_&D07Z0Z
MX[-2-!%]E7##:16:F#E!K5&FID2OYVC![9^FU%RNH/F6;)Q1_UOG""49JZLC
M1KY&O-%.%V+WP]ZP*$;;Z^OC\;@WJ$W7@\5WUS_L]6"X>FT56NMAC$<T8!*!
M%D*N 7_S5:<825MP84C0T2Z<U^MV(MO<*CI 4X>##XLX:U"/OU'2_IGKKJ\3
M./_6[8JW6J7)MCB7 [4#RI]*,@$8$-UNN)^Q>W3R[XJ[Q_9\3<\B8^&^];.#
ME.+ )@2B:C[!_E?[!Z?'XO#X]/1\_^CHY/V[-RL;*_S[\GS_L/H=M@S48IPV
MY<B!M>IO.PA"23$D96W\XZX*Z^JBHH%C?D&#PDH3X'_QP@&M.*I6S)!>N)PQ
MM>+5$=U;N:#_D5#X$]JZ0W$1CN'773^+VH8_D+:;RGQ][TV"OXJR&F!<)S1Z
M '[5DN;_/;KC#($ /Y8VZ9X:0V.;=NNR:N&X;^>(W]PLH?))ZIP+?E9GZM4Y
M;8BYJOU%R0\55M[H=57W5IK#&5W5)N*"?#Z;]M:W7O7$U$C47N2]56@94W94
MXREK7-[16)QR9H,=T,*W=%B@"Q T(>1N=$2G'GS"O<!(/2!03_P'$M$4D@LO
M!@])$X9]H22<&5!T:#J8N- V=E5+%06ICO4(A$-GM5.]B52J47;./_:3R?FG
M5-F&9WX<'YY3AS\\9T6@//!C"2H#$X@"@#P@9X<JC;1,//]-D4,QU% JE"YY
MG%:8;1*]/N+5=8Z,-*L&>U.%4V9TY^"A!J@8#U4^Y;F::=0/J%^+)=54MG-7
M=05U3+?U$^&[YK_US9!J;T^LCZ6>K\<[ZH\WTZL9Q:.-<_$4?7,<'!X9;HI+
M NL#?DV0BF2C:\"@[;,(B"?(1*%O0$5NFO)<#)SY\8OC^5R[%4U\8Z%193=:
M O)&ZI0/487I-(CR8<FI!032D"]E8\-YF,=ZB)/XMZ%5R@IOQ!*2A1CRS#1.
M8:ST0EYS<2Y,E%;1B:_TX&>,_<H14_>WI^YW)P":>Z*D"#)^F7)D0]2:.62T
M6_V2AM:5#%4O=:P=^ N3,.FJ416? 7"XZXE]ZDO7D><^LU5ST<5S ELT]'Q5
M0K8)_>A8>OC8R8P\P24M?9!3S(2&R,*6QZT<?XD71%C0# *3>U1!CSEOZ)HG
MDCR#I/828QO*("T(W:?['=@\+^KA#'_3J?>9-.X7T;;U!1(*-Z$\YPD.].EG
M,X[P4'H%EU9$)<("J8-^CY3W=43["P6-V0"2H(KJLEI,X( R-8[XMN ;5Q#7
M6#_AE+R-6.QC+.J$V*3F/.@3KLGUJI=@.=$\5J"0:5E^8(3&EP\CSK,8DMN,
MV9N)LB?>!I;KS^_GN^+)9P8%\T3E-,M6C0AR5K9\"+X 9</,D,=*NFLE$Q]_
MN1'B+\WP##-G_&BR3VT&L5IY3S&TIAP,@_>1L4:^C !4X!"\G0]ACAJ841$H
M^@<<PQ&'8U_@1Z:BW_2RM1T4X.YZ)JV%B.WOG*TR]"%M/N#K -8/[PT<I+I^
M!KRLUOG3#US?4E>)5A[9<B#V$^H"U3FE6G?GWBJWX-9/M)'R\#Q<.IS.^BF;
ME5PJ=9#A0)FO=Q):'*J"19)W&#>$G828TE'IV:HFTNXNOLA&C0P[U.$6HE7L
M%74LH5M]CI)-VJ'$4VF%TI\'_\R>]<<[M70-J! 7M9<ERL58YVO NT3B%.[N
MG7S[>NEWC+X;11%+OY]3\Q Q@OR?XLE;JEDW-[H_U44%M0:%KUGFKZV]I#A.
M0WM$VVDI<7Q(A,ZD11"H[K=]&P<_S;'PI*Z/+I2_CN.VE_ "/"2I++!\O'_8
MJZI4]\-B5W79I%EF2QSLG:E$RZ?S@.7JB "ITYQS?O&#1B[*X\\.U+]ZU_V+
MW71XH(W_?$?\[ ^JV^)4NN);5_]/TJC^TIZQ3O_RUO]37/H7N_\#4$L#!!0
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M.]K^B3A2?2I7)2!8VR]NP_]6OK[J)$E""6^_2X8>K#YK2&W"[I@Q"JP;3+V
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MM\O@Z+S5X1,]K:*(2X$5YBB$H^N/!@-E0C,V_T1"0JVSRF6NZ>3;F<FLW$0
M>Z)X0S29B$;YT2Z#&?+9=)G/XT;\$!(OD!XT#^:S(-P,0C##9W4M$0M J8JN
M)+C*8SPTQ6-=)A*VT1DL\7X1);[F\L"3*$E33VDQW*'T9F-I08. &K@_F^+5
M"3)A6RGH.?BCA'^4<S!%^!O^+.4T^+/,@86_5'@P:2AR-QCXXI(5L&CRQ'(
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M?W5;]C]!\*UJENGUYIU>:WRLZ^W!QS>"(IL=UQSC?_O!P-[_?U!+ P04
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MY*_'#,(J)7\XK1O+?P"'-2+'ITW0?PI.#7O"%)2#;QN!MIVJJ>,?4$L#!!0
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MQ5[PL!JV0M)2AH>*S5X?,&4,$D$^3JPK7.4-#>NK9%JYNU> +;8.KP W"H.
MP.;(? 6XO'I2BEQWLV24$PR,".UB9YUL,57W<:,LC"XV#1D]7'ROA<;'%UEF
M=TGO'AF%'Q P):YZ&C*G>ELO#Z+' 5-ZKQ<R5.@\78V7&28R^_#=*',VL^MV
MZHE<%031N[H;8YI6Y8Y[\S>>Y&+/,[;9;&EUE\?VW""@<]7+G395CUM%0?1^
MES.=A$J+VF+'6"Q8FD1)GM#UK^+DDR?8UBJ;R!40L$%%@ZD( @70EL[!08B4
MTC$$=YQ("(GHB.(E0)E8B-\^/%AG^RZQ*RCZ#2LX8&40D/3:TV$1 >.H$8'*
M$%3$^,5FGF5;PM\$CR7$$T*@>0 D0Q\B3I#)7JC*0)]L+4BT%?/C_GBZ6B9Y
M:CNY-"7.YB3 7#TC:>5!L &8TEDHRA![0,?3OZW^CE24X^Z_84N.9>[8Q7ZS
M8BF0?<JJ<@5!AT7%@442! JP+YV&&X8J*2JU/K)3M<Q:FJ.5NP+ :DMU?:LP
MB$ZW.3*^_*V^]C3D7^ZB1V&* "\DV&6NAWZ;27WX;VJ"0*##F'%24DF1TOIX
M(>$P9:W[%P%K;XN =<\B8!WB(F ]=!&P]K8(4+LM4X2(<>EVE29K#"0G[%2[
MAJ+#LLZ'11H4*K _<,RH0] AQG5&RR+%F4S/SS?%_J_$!TLK 9VSG)9=-NND
MEC91$(QT.3/26I9)YQIB)-6NN=C&24[BTLQ50C&-$IS6Z1%M5\3[0YS1,M!\
M#4Z//@R&AIDT<"K#5"[#.O"0ZM+UI?3R 8S?2)K^0MDK71"<,4KB\EJ*[4Y1
MM][M$S,]MML/S0#B(' :XA!X=$8&C9]D%%)AU94P+R1]8^F6YI@7[Y)SV\@$
MZ-R2 ]AL$Z.) B+%[@P@I!:C4NWG!>TR>T2]R"I_=PAL("1W_+IVIVGMK6VK
M-B!F.@U"[W!7.3\.:^,RRM,KECF1OQ>1O) O.,>5-["]D-SU2Y5=IO6W*6W:
M@!#J- B^/UG'R%0Q6#'E+64,GXFEUIIU/"6NJ=PGCC$LFKEC:DE >-A\=620
MX4AIO;"PV. T_;S-$DHR>"+25&Y9L%ILL]"2!,2"S1? 0B%%2NN%A<L-X6LQ
MO?W,V6O^6.5G!=L&J-VRT6FYS8A5&A K7?X 9E0(*F-42ET_\.P."<7++(MP
M2RU2Q]B 9C5F#%U(P$#F#%I2$LGK+3<L1TN&OF8$Y8\$758_0]?,!%_6X^N7
M1J)(OA!1KLIIC+D-H2ZQ\U\= 0T;OSUB*(, J=<>_#LD=012(8ZIN14,\^9Y
M7&%BGI,-^+9#?X@K@H::5QSUZ8.@::!)G:DBK'UR700B&>DSFU$SN3V\Q&N)
M'*^,+0:UA7%#$00CH"UH6=S\K0 _N?.VJS2)KE*&X:LL+8WCC'FF/2U9WD$0
M$ &F*RA%7B%$A=)+_W_&](EOG_-H?\=91(A\RBJK1ZN^ZV\#H]TR\Z8FM6D:
M%!H09V_Q"Q!XJ (UZOC0F+%\7LR3#XW+;&XL>EH\8G$ ;[=Y)F=080R^"MX9
MY/CVPH &:#<9.B("0F^ 3>B&0Q&)BM /J Q&C6A/YV?9(0L@B3_O[\D#X?*]
M@R79Y9_%CIXZSC &Q+H^>QO<'/UDKC<P" C?ZA8ZU<M0LP*TDL^(556@WV4E
MJ*C%]OOES4W7XI/8K#:)OU8X(V++?P%02P,$%     @ KX"?6X&S1\Q;!P
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MA.FB<Z3KUAYP[Z@MOG&_W'M8[9'_ 5!+ 0(4 Q0    ( *^ GUNTU>2OE+P
M "K+!  *              "  0    !E>#$P+3$N:'1M4$L! A0#%     @
MKX"?6V7GH#A 70  R/\"  H              ( !O+P  &5X,3 M,BYH=&U0
M2P$"% ,4    " "O@)];74?Z ?(3  !,=   "@              @ $D&@$
M97@Q,"TS+FAT;5!+ 0(4 Q0    ( *^ GUOJH7>*8B\  %TC 0 *
M      "  3XN 0!E>#$P+30N:'1M4$L! A0#%     @ KX"?6P\P9))*1
M\^D!  D              ( !R%T! &5X-"TQ+FAT;5!+ 0(4 Q0    ( *^
MGUO'UH]IO48  (3R 0 )              "  3FB 0!E>#0M,BYH=&U02P$"
M% ,4    " "O@)];$'&OD$M*  !O' ( "0              @ $=Z0$ 97@T
M+3,N:'1M4$L! A0#%     @ KX"?6YG(=3TM#0  N#L   H
M ( !CS," &5X.3DM,2YH=&U02P$"% ,4    " "O@)];W:DNA] B  #@#0$
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7;%!+!08     #  , +L"  #T>0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gctk-20251229.xsd" xlink:type="simple"/>
    <context id="AsOf2025-12-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2025-12-29</startDate>
            <endDate>2025-12-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2025-12-29" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-12-29" id="Fact000004">0001506983</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-12-29" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-12-29" id="Fact000010">2025-12-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-12-29" id="Fact000011">GLUCOTRACK, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-12-29" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-12-29" id="Fact000013">001-41141</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-12-29" id="Fact000014">98-0668934</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-12-29" id="Fact000015">301     Rte. 17 North</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-12-29" id="Fact000016">Ste. 800</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-12-29" id="Fact000017">Rutherford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-12-29" id="Fact000018">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-12-29" id="Fact000019">07070</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-12-29" id="Fact000020">(201)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-12-29" id="Fact000021">842-7715</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-12-29" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-12-29" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-12-29" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-12-29" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-12-29" id="Fact000026">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-12-29" id="Fact000027">GCTK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-12-29" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-12-29" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
